<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004886" GROUP_ID="LIVER" ID="095203061815425145" MERGED_FROM="" MODIFIED="2008-11-20 10:55:17 +0100" MODIFIED_BY="dimitrinka nikolova" NOTES="&lt;p&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.5&lt;br&gt;Exported from Review Manager 4.2.2&lt;/p&gt;&lt;p&gt;Old title: Metronidazole with or without imaging-guided percutaneous treatment for amoebic liver abscess&lt;br&gt;Old title: Metronidazole with or without imaging-guided percutaneous treatment for amebic liver abscess&lt;/p&gt;" NOTES_MODIFIED="2008-11-20 10:55:17 +0100" NOTES_MODIFIED_BY="dimitrinka nikolova" REVIEW_NO="01" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.9">
<COVER_SHEET MODIFIED="2008-11-20 09:51:39 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<TITLE MODIFIED="2008-06-12 13:43:42 +0100" MODIFIED_BY="dimitrinka nikolova">Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated amoebic liver abscess</TITLE>
<CONTACT>
<PERSON ID="4DD5730482E26AA201BA4B54069A499E" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Norberto</FIRST_NAME>
<MIDDLE_INITIALS>C</MIDDLE_INITIALS>
<LAST_NAME>Chavez-Tapia</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>khavez@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Gastroenterology</DEPARTMENT>
<ORGANISATION>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</ORGANISATION>
<ADDRESS_1>Vasco de Quiroga #5</ADDRESS_1>
<ADDRESS_2/>
<CITY>Mexico City</CITY>
<ZIP>14000</ZIP>
<REGION>Distrito Federal</REGION>
<COUNTRY CODE="MX">Mexico</COUNTRY>
<PHONE_1>(5255) 54870900, ext: 2715</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2008-11-20 09:51:39 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<PERSON ID="4DD5730482E26AA201BA4B54069A499E" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Norberto</FIRST_NAME>
<MIDDLE_INITIALS>C</MIDDLE_INITIALS>
<LAST_NAME>Chavez-Tapia</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>khavez@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Gastroenterology</DEPARTMENT>
<ORGANISATION>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</ORGANISATION>
<ADDRESS_1>Vasco de Quiroga #5</ADDRESS_1>
<ADDRESS_2/>
<CITY>Mexico City</CITY>
<ZIP>14000</ZIP>
<REGION>Distrito Federal</REGION>
<COUNTRY CODE="MX">Mexico</COUNTRY>
<PHONE_1>(5255) 54870900, ext: 2715</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="CFE352B182E26AA2013BE41631D6383E" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Jorge</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Hernandez-Calleros</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>jhcalleros@yahoo.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Gastroenterology</DEPARTMENT>
<ORGANISATION>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Mexico City</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="MX">Mexico</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="BAF0AE0682E26AA2004627994FFA88F2" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Felix</FIRST_NAME>
<MIDDLE_INITIALS>I</MIDDLE_INITIALS>
<LAST_NAME>Tellez-Avila</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>felixtelleza@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Gastroenterology</DEPARTMENT>
<ORGANISATION>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Mexico City</CITY>
<ZIP>1400</ZIP>
<REGION>Distrito Federal</REGION>
<COUNTRY CODE="MX">Mexico</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="CFE34FE282E26AA2013BE416E7AA776F" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Aldo</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Torre</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>detoal@yahoo.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Gastroenterology</DEPARTMENT>
<ORGANISATION>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Mexico City</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="MX">Mexico</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="BAF0B1B082E26AA2004627999AF29DE3" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Misael</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Uribe</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1/>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Gastroenterology</DEPARTMENT>
<ORGANISATION>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</ORGANISATION>
<ADDRESS_1>Vasco de Quiroga #15. Seccion XVI. Del. Tlalpan</ADDRESS_1>
<ADDRESS_2/>
<CITY>Mexico City</CITY>
<ZIP>14000</ZIP>
<REGION/>
<COUNTRY CODE="MX">Mexico</COUNTRY>
<PHONE_1>+52 5555733418</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-11-13 23:21:59 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="5" MONTH="4" YEAR="2008"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="5" MONTH="4" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="10" MONTH="10" YEAR="2011"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2004"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2004"/>
</DATES>
<WHATS_NEW>
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="10" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-04-10 10:42:08 +0100" MODIFIED_BY="dimitrinka nikolova"/>
<SOURCES_OF_SUPPORT MODIFIED="2008-04-30 16:59:36 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2008-04-30 16:59:27 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2008-04-30 16:59:27 +0100" MODIFIED_BY="[Empty name]">
<NAME>None</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2008-04-30 16:59:36 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2008-04-30 16:59:36 +0100" MODIFIED_BY="[Empty name]">
<NAME>None</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-11-20 10:55:17 +0100" MODIFIED_BY="dimitrinka nikolova">
<SUMMARY MODIFIED="2008-11-12 19:13:59 +0100" MODIFIED_BY="dimitrinka nikolova">
<TITLE MODIFIED="2008-08-12 13:43:35 +0100" MODIFIED_BY="[Empty name]">Percutaneous needle aspiration does not seem to help patients with uncomplicated amoebic liver abscesses</TITLE>
<SUMMARY_BODY MODIFIED="2008-11-12 19:13:59 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Amoebiasis (disease caused by the protozoan <I>Entameoba histolytica</I>) remains an important clinical problem in countries around the world, with 40 to 50 million people affected. Mortality rates are significant, with 40,000 to 110,000 deaths each year. In fact, amoebiasis mortality is second only to malaria as cause of death from protozoan parasites. The most common complication of amoebiasis is the formation of a pus-filled mass inside the liver (liver abscess). Metronidazole is the drug of choice for treatment of amoebic liver abscesses followed by a luminal agent to eradicate the asymptomatic carrier state. Cure rates are 95% with disappearance of fever, pain, and anorexia within 72 to 96 hours. This review compares the standard treatment with a more invasive alternative, where pus-filled mass is drained by image-guided percutaneous procedure (performed through the skin). Seven low quality randomised trials were included. All the seven studies included a total of 310 patients, but due to selective outcome reporting bias, less patients could be included in our analyses. Pooled analysis of three homogenous trials showed that needle aspiration did not significantly increase the proportion of patients with fever resolution. Benefits could be observed in resolution time of pain and tenderness. No additional benefit has been found with percutaneous needle aspiration plus metronidazole <I>versus</I> metronidazole alone for uncomplicated amoebic liver abscesses in hastening clinical and radiologic resolution. However, this conclusion is based on trials with methodological flaws and with insufficient sample sizes, and requires further confirmation in larger well-designed, randomised trials.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-11-18 11:36:33 +0100" MODIFIED_BY="dimitrinka nikolova">
<ABS_BACKGROUND MODIFIED="2008-11-10 19:00:46 +0100" MODIFIED_BY="[Empty name]">
<P>Metronidazole is the standard of care for uncomplicated amoebic liver abscesses (considering that complicated liver abscesses are those localized in left lobe, multiple, and/or pyogenic abscesses). However, a subset of patients with amoebic liver abscesses remain symptomatic, with a significant risk of rupture of the abscess into the peritoneum. The role of image-guided percutaneous therapeutic aspiration in these patients remains controversial.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2008-11-13 23:21:33 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the beneficial and harmful effects of image-guided percutaneous procedure plus metronidazole versus metronidazole alone in patients with uncomplicated amoebic liver abscess.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-11-12 19:10:34 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>We searched the<I> Cochrane Hepato-Biliary Group Controlled Trials Register</I>, the <I>Cochrane Central Register of Controlled Trials </I>in <I>The Cochrane Library</I> (Issue 2, 2007), <I>MEDLINE</I> (1966 to November 2007), <I>EMBASE</I> (1988 to September 2007), and <I>Science Citation Index Expanded </I>(1945 to September 2007).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-11-13 23:22:18 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised or quasi-randomised trials comparing an image-guided percutaneous procedure plus metronidazole versus metronidazole alone in patients with uncomplicated amoebic liver abscess.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-11-18 11:34:45 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Inclusion criteria, trial quality assessment, and data extraction were done in duplicate. We calculated relative risks (RR) and mean differences, and checked for heterogeneity by visual inspection of forest plots and chi-squared and I<SUP>2</SUP> tests.<BR/>
</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-11-18 11:36:33 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Seven low quality randomised trials were included. All studies included a total of 310 patients, but due to selective outcome reporting bias, less patients could be included in our analyses. Pooled analysis of three homogenous trials showed that needle aspiration did not significantly increase the proportion of patients with fever resolution (RR 0.60, 95% confidence interval (CI) 0.22 to 1.61). Sensitivity analysis according to trial quality preserved these findings. Trials that evaluated resolution of abdominal pain, days to resolution of fever, pain, resolution of abscess cavities, reduction in liver size, and duration of hospitalisation were heterogeneous. The benefits in the number of days to resolution of pain (MD -1.59, 95%CI -2.73 to -0.42), number of days to resolution of abdominal tenderness (MD -1.70, 95%CI -2.86 to -0.54), and duration of hospitalisation (MD -1.31, 95%CI -2.05 to -0.57) were observed in the needle aspiration group only.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-11-13 23:26:17 +0100" MODIFIED_BY="[Empty name]">
<P>Therapeutic aspiration in addition to metronidazole to hasten clinical or radiologic resolution of uncomplicated amoebic liver abscesses cannot be supported or refuted by the present evidence. The trials lack methodological rigour and adequate sample size to conclude on the presence of effectiveness of adjunctive image-guided aspiration plus metronidazole<I> </I>versus metronidazole alone. Further randomised trials are necessary.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-20 10:27:25 +0100" MODIFIED_BY="dimitrinka nikolova">
<BACKGROUND MODIFIED="2008-11-18 10:47:10 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>
<I>
<B>Epidemiology<BR/>
</B>
</I>Amoebiasis remains an important clinical problem in countries around the world, with 40 to 50 million people affected. Mortality rates are significant, with 40,000 to 110,000 deaths each year. In fact, amoebiasis mortality is second only to malaria as cause of death from protozoan parasites (<LINK REF="REF-Hughes-2000" TYPE="REFERENCE">Hughes 2000</LINK>; <LINK REF="REF-Stanley-2003" TYPE="REFERENCE">Stanley 2003</LINK>). Amoebiasis is prevalent in countries where public health and personal hygiene are sub-optimal (<LINK REF="REF-Hughes-2000" TYPE="REFERENCE">Hughes 2000</LINK>; <LINK REF="REF-Stanley-2003" TYPE="REFERENCE">Stanley 2003</LINK>). Increasing travelling, immigration of individuals from endemic areas, growth of the homosexual population, and increasing immunosuppression are factors contributing to the increased risk for amoebiasis worldwide (<LINK REF="REF-Hughes-2000" TYPE="REFERENCE">Hughes 2000</LINK>). Endemic areas are the Indian subcontinent, Southeast Asia, Africa, and South and Central America (<LINK REF="REF-Reed-1992" TYPE="REFERENCE">Reed 1992</LINK>).</P>
<P>
<I>
<B>Pathogenesis</B>
</I>
<BR/>Ingestion of <I>Entamoeba</I> (E) <I>histolytica</I> cysts through food or water contaminated by human faeces causes amoebiasis. Asymptomatic colonisation of the gastrointestinal tract is common, but some patients develop invasive disease of the colon (<LINK REF="REF-Hughes-2000" TYPE="REFERENCE">Hughes 2000</LINK>; <LINK REF="REF-Stanley-2003" TYPE="REFERENCE">Stanley 2003</LINK>). The amoebae can breach the colonic mucosal barrier and travel through the portal circulation to the liver. <I>E histolytica</I> blocks intrahepatic portal venules, and proteolytic enzymes digest the parenchymal cells forming a liquefied central area of necrosis, this causes amoebic liver abscesses.</P>
<P>Amoebic liver abscess is the most common extraintestinal manifestation of <I>E. histolytica</I> infection. All age groups are affected, but it is 10 times more common in the 20 to 40-year old age group (<LINK REF="REF-Ruiz_x002d_Palacios-1997" TYPE="REFERENCE">Ruiz-Palacios 1997</LINK>; <LINK REF="REF-Petri-1999" TYPE="REFERENCE">Petri 1999</LINK>) and 12 times more common in men than women. If left untreated, amoebic liver abscesses can be fatal, with death from sepsis. With early diagnosis and treatment with metronidazole alone, mortality has dropped to less than 1% (<LINK REF="REF-Ravdin-1995" TYPE="REFERENCE">Ravdin 1995</LINK>).</P>
<P>
<I>
<B>Diagnosis</B>
</I>
<BR/>Ultrasound and computed tomography scans are non-invasive, equally sensitive imaging modalities for the detection of amoebic liver abscesses (<LINK REF="REF-Hughes-2000" TYPE="REFERENCE">Hughes 2000</LINK>; <LINK REF="REF-Stanley-2003" TYPE="REFERENCE">Stanley 2003</LINK>), but they cannot specifically differentiate amoebic from pyogenic abscess. Serum antibody detection is an important confirmatory test in the case of amoebic liver abscesses. Serologic tests are about 90% sensitive for amoebic liver abscess, with important limitations within the first week of the disease, and complementary serological assays must be performed (<LINK REF="REF-Petri-1999" TYPE="REFERENCE">Petri 1999</LINK>).</P>
<P>
<I>
<B>Treatment<BR/>
</B>
</I>Metronidazole is the drug of choice for treatment of amoebic liver abscesses followed by a luminal agent to eradicate the asymptomatic carrier state (<LINK REF="REF-Hughes-2000" TYPE="REFERENCE">Hughes 2000</LINK>). Cure rates are 95% with disappearance of fever, pain, and anorexia within 72 to 96 hours (<LINK REF="REF-Ravdin-1995" TYPE="REFERENCE">Ravdin 1995</LINK>; <LINK REF="REF-Reed-1998" TYPE="REFERENCE">Reed 1998</LINK>). Most abscesses heal from the periphery usually in four weeks after initiating therapy. Mean time to complete radiologic resolution is three to nine months with greater than 50% reduction in liver size within a week (<LINK REF="REF-Hughes-2000" TYPE="REFERENCE">Hughes 2000</LINK>).</P>
<P>However, approximately 10% to 15% of patients remain symptomatic despite of proper drug treatment. In recent years, imaging-guided percutaneous treatment with needle aspiration or catheter drainage has replaced surgical intervention as the procedure of choice for therapeutically reducing abscess size (<LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>). Simple needle aspiration is less invasive, less expensive, allows for aspiration of multiple abscesses in the same session, and avoids problems related to follow-up catheter care (<LINK REF="REF-Giorgio-1995" TYPE="REFERENCE">Giorgio 1995</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>). Therapeutic aspiration is the standard of care in complicated liver abscesses, which include those with high risk of abscess rupture; left lobe liver abscesses, because of increased frequency of peritoneal leak or rupture into the pericardium; no response to drug therapy within five to seven days; bacterial co-infection, and uncertainty in diagnosis (<LINK REF="REF-Haque-2003" TYPE="REFERENCE">Haque 2003</LINK>; <LINK REF="REF-Stanley-2003" TYPE="REFERENCE">Stanley 2003</LINK>).</P>
<P>It is important in clinical practice to identify subgroups of patients with amoebic liver abscesses who will benefit from ultrasound- or computed tomography-guided therapeutic aspiration. Spontaneous rupture of the abscess into the peritoneum can occur in 2% to 7% of patients (<LINK REF="REF-Ravdin-1995" TYPE="REFERENCE">Ravdin 1995</LINK>), and mortality rates ranged from 2% to 18% (<LINK REF="REF-Sharma-1996" TYPE="REFERENCE">Sharma 1996</LINK>). Prediction of rupture is difficult in a setting without a high index of suspicion or without ultrasound monitoring to ascertain changes in the thickness between the skin surface, the liver capsule, and the cavity margin. Existing evidence, however, on the role of image-guided percutaneous therapy is conflicting. Clinical trials are small with debatable results and we have been unable to identify systematic reviews or meta-analyses on this topic. If needle aspiration hastens response to amoebicidal drugs and clinical recovery, this can potentially improve the quality of life, shorten hospital stay, and possibly reduce health care costs especially in developing countries.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-06-12 14:09:24 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>To determine the beneficial and harmful effects of image-guided percutaneous procedure plus metronidazole compared with metronidazole alone in patients with uncomplicated amoebic liver abscess.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-18 10:51:00 +0100" MODIFIED_BY="dimitrinka nikolova">
<SELECTION_CRITERIA MODIFIED="2008-11-18 10:49:38 +0100" MODIFIED_BY="dimitrinka nikolova">
<CRIT_STUDIES MODIFIED="2008-11-18 10:48:26 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>All randomised clinical trials were included in the review regardless of language, blinding, and publication status. In case there were too few randomised clinical trials, quasi-randomised clinical trials were considered for inclusion in an exploratory analysis to assess adverse events.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-11-18 10:49:22 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Adult patients admitted to the hospital with a clinical diagnosis of uncomplicated amoebic liver abscesses confirmed by a positive serologic result for <I>E histolytica</I> either by enzyme-linked immunosorbent assay (ELISA) or indirect hemagglutination assay (IHA), and with characteristic radiologic features on diagnostic imaging (computed tomography scan or ultrasound) confirming liver abscesses.</P>
<P>The trials that included patients with pyogenic abscesses, impending rupture, and/or other findings suggestive of complicated liver abscess, were not considered in this review.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-11-18 10:49:38 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Image-guided percutaneous procedure, either needle aspiration or catheter drainage, plus metronidazole versus metronidazole in a similar dosage and duration alone.</P>
<P>Any collateral interventions if used equally in all intervention groups were allowed.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-10-23 09:05:18 +0100" MODIFIED_BY="[Empty name]">
<P>
<I>
<B>Primary outcomes</B>
</I>
</P>
<OL>
<LI>Mortality.</LI>
<LI>Proportion of patients without resolution of abscess size on image follow-up.</LI>
<LI>Clinical improvement or response to treatment as follows:</LI>
</OL>
<P>Lack of resolution of fever expressed as:</P>
<UL>
<LI>proportion of patients remaining febrile;</LI>
<LI>days to resolution of fever;</LI>
</UL>
<P>Lack of resolution of pain expressed as:</P>
<UL>
<LI>proportion of patients without resolution of pain;</LI>
<LI>days to resolution of pain;</LI>
</UL>
<P>Lack of resolution of abdominal tenderness expressed as:</P>
<UL>
<LI>proportion of patients without resolution of tenderness;</LI>
<LI>days to resolution of tenderness;</LI>
<LI>proportion of patients without reduction in liver size.</LI>
</UL>
<P>
<I>
<B>Secondary outcomes<BR/>
</B>
</I>4.<I>
<B> </B>
</I>Duration of hospitalisation.<BR/>5. Adverse events. Occurrence of complications, that is, rupture of abscess cavity and number of patients requiring surgical intervention.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-11-13 23:29:36 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the following databases: <I>The Cochrane Hepato-Biliary Group Controlled Trials Register </I>(<LINK REF="REF-Gluud-2008" TYPE="REFERENCE">Gluud 2008</LINK>), <I>The Cochrane Central Register of Controlled Trials</I> (<I>CENTRAL</I>) in <I>The Cochrane Library </I>(Issue 2, 2007), <I>MEDLINE</I> (1950 to November 2007), <I>EMBASE</I> (1980 to September 2007) and <I>Science Citation Index Expanded</I> (1945 to September 2007) (<LINK REF="REF-Royle-2003" TYPE="REFERENCE">Royle 2003</LINK>). The search strategies are displayed in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>. We reviewed the reference lists of the retrieved articles for potentially relevant studies, including review articles on the topic. We contacted the corresponding authors of relevant studies identified from the initial search and experts in the field for any information on unpublished articles.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-11-18 10:51:00 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>
<B>Study selection</B>
<BR/>Two authors (NC, JH) independently reviewed the search output for potentially relevant trials for inclusion. Two authors (NC, JH) assessed the trials for potential inclusion. We excluded studies that do not meet the inclusion criteria and stated the reason in the '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>'. Disagreements were settled by discussion with a third co-author (FT). Each trial was assessed for possible multiple publications from the same data set to ensure that each trial is included only once in the review. We contacted the authors of the studies to obtain or verify missing information in the trial.</P>
<P>
<B>Assessment of bias risk by components of methodological quality<I>
<BR/>
</I>
</B>Two authors (NC, JH) independently assessed the bias risk by the following components of methodological quality of included studies (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>; <LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>; <LINK REF="REF-Kjaergard-2001" TYPE="REFERENCE">Kjaergard 2001</LINK>; <LINK REF="REF-Wood-2008" TYPE="REFERENCE">Wood 2008</LINK>):</P>
<P>
<I>
<B>Generation of the allocation sequence</B>
</I>
<BR/>
</P>
<UL>
<LI>Adequate, if the allocation sequence was generated by a computer or random number table. Drawing of lots, tossing of a coin, shuffling of cards, or throwing dice were also considered as adequate if a person who was not otherwise involved in the recruitment of participants performed the procedure.</LI>
<LI>Unclear, if the trial was described as randomised, but the method used for the allocation sequence generation was not described.</LI>
<LI>Inadequate, if a system involving dates, names, or admittance numbers were used for the allocation of patients.</LI>
</UL>
<P>
<I>
<B>Allocation concealment </B>
</I>
<B>
<BR/>
</B>
</P>
<UL>
<LI>Adequate, if the allocation of patients involved a central independent unit, on-site locked computer, identically appearing numbered drug bottles or containers prepared by an independent pharmacist or investigator, or sealed envelopes.</LI>
<LI>Unclear, if the trial was described as randomised, but the method used to conceal the allocation was not described.</LI>
<LI>Inadequate, if the allocation sequence was known to the investigators who assigned participants or if the study was quasi-randomised.</LI>
</UL>
<P>
<I>
<B>Blinding</B>
</I>
<B>
<BR/>
</B>
</P>
<UL>
<LI>Adequate, if the trial was described as double blind and the method of blinding involved identical placebo or active drugs. Due to the use of image-guided aspiration or catheter drainage as an intervention, we are well aware that it may be very difficult to properly blind such trials.</LI>
<LI>Unclear, if the trial was described as double blind, but the method of blinding was not described.</LI>
<LI>Not performed, if the trial was not double blind.</LI>
</UL>
<P>
<I>
<B>Follow-up</B>
</I>
<BR/>
</P>
<UL>
<LI>Adequate, if the numbers and reasons for dropouts and withdrawals in all intervention groups were described or if it was specified that there were no dropouts or withdrawals.</LI>
<LI>Unclear, if the report gave the impression that there had been no dropouts or withdrawals, but this was not specifically stated.</LI>
<LI>Inadequate, if the number or reasons for dropouts and withdrawals were not described.</LI>
</UL>
<P>Furthermore, we registered whether or not the randomised clinical trials used 'intention-to-treat' analysis (<LINK REF="REF-Gluud-2001" TYPE="REFERENCE">Gluud 2001</LINK>) and sample size calculation.</P>
<P>Any disagreement was resolved by discussion and settled by a third author (FT). We contacted the trial author for clarification as necessary.</P>
<P>
<B>Data extraction <I>
<BR/>
</I>
</B>Two authors (NC, JH) independently extracted data for each of the outcomes from each relevant study using a pre-designed data extraction form. We extracted the following information on study characteristics: population studied, interventions performed, and outcomes evaluated. These include trial setting, criteria for inclusion and exclusion of participants, details on interventions performed including dose of medications, duration of treatment, and co-interventions. Outcome measures to be extracted included mortality, symptom resolution, radiologic resolution of abscess cavity, and length of hospital stay. We also extracted adverse events reported such as occurrence of complications, non-responders, and those needing surgical intervention.</P>
<P>
<B>Data analysis </B>
<BR/>Data were entered in Review Manager Version 5.0 (<LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>) by one author (NC) and checked by two other authors (JH, FT). Continuous outcomes were expressed as mean differences with 95% confidence intervals while dichotomous outcomes were expressed as relative risks with a 95% CI. For each outcome we extracted the number of participants assigned to each group and whenever possible extracted data to allow for an intention-to-treat analysis. If the number randomised and the numbers analysed were inconsistent, we reported this as the percentage lost to follow-up. For binary outcomes, the number of participants experiencing the event in each group was recorded. For continuous outcomes, the arithmetic means and standard deviations for each group were extracted. Any disagreement was resolved by discussion with reference to the trial report and resolution by a co-author (FT). For outcomes for which data were not reported or were reported in a different format, we contacted the authors for clarification. We checked for heterogeneity among trials by visual inspection of the forest plots and by using the chi-squared and I<SUP>2</SUP> tests for heterogeneity (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>), using a P-value less than 0.10 as the cut-off level for statistically significant heterogeneity. When heterogeneity was detected, potential sources of heterogeneity according to intervention, participants, trial setting, and trial quality were explored. We conducted subgroup analyses according to study quality and subgroup analysis according to type of percutaneous procedure where sufficient data were available. We analysed data by both the fixed-effect model analysis and random-effects model analysis, but we only reported the former in the text if the outcome of both analyses were the same. Outcomes were analysed as reported in the trial, that is, either per protocol or as intention-to-treat analysis.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-11-20 10:27:25 +0100" MODIFIED_BY="dimitrinka nikolova">
<STUDY_DESCRIPTION MODIFIED="2008-11-18 11:03:41 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>A total of 124 studies were retrieved from the broad search strategies used. After the elimination of editorials, reviews, and repeated reports, seven trials met the inclusion criteria, and 31 studies were excluded from inclusion in this review. The 31 excluded studies with details on why they failed to meet the inclusion criteria are outlined in the table of '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>'. Details of the seven included trials are outlined in the table of '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>'. All seven trials were published in English. The number of participants per trial ranged from 29 to 52 participants. Unfortunately a detailed description of included participants (eg, anatomical considerations, serological status, and a precise definition of disease status) was not provided and limits the overview of the included population.</P>
<P>Considering the lack of a clear definition of large abscess in the included studies, the magnitude of the abscess was diverse. In the <LINK REF="STD-Blessman-2003" TYPE="STUDY">Blessman 2003</LINK> et al trial, abscess larger than 10 cm were excluded, but in all other trials no information on the size of the abscess was stated. Additionally, a significant difference on the abscess size among groups was observed in the trial by <LINK REF="STD-Sharma-1989" TYPE="STUDY">Sharma 1989</LINK> et al, and some information about the size was provided in <LINK REF="STD-de-la-Rey-Nel-1989" TYPE="STUDY">de la Rey Nel 1989</LINK>. Most of the trials involved abscess within the range of 6 cm to 8 cm.</P>
<P>
<B>Population studied<BR/>
</B>Six trials were performed in developing countries where amoebic liver abscesses are prevalent and one trial was performed in the United States (<LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>). All trials involved a total of 310 patients diagnosed with uncomplicated amoebic liver abscess based on clinical, serologic, and radiologic criteria. The mean age ranged from 35 to 46 years, with the majority of trials involving a greater number of males than females.</P>
<P>
<B>Description of interventions<BR/>
</B>Five trials employed ultrasound-guided aspiration of the abscess cavities by needle aspiration (<LINK REF="STD-de-la-Rey-Nel-1989" TYPE="STUDY">de la Rey Nel 1989</LINK>; <LINK REF="STD-Sharma-1989" TYPE="STUDY">Sharma 1989</LINK>; <LINK REF="STD-Arredondo-1993" TYPE="STUDY">Arredondo 1993</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>; <LINK REF="STD-Blessman-2003" TYPE="STUDY">Blessman 2003</LINK>) and two trials by insertion of a temporary catheter (<LINK REF="STD-Widjaya-1991" TYPE="STUDY">Widjaya 1991</LINK>; <LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>). In all trials, aspiration or drainage of the abscess cavities were performed until drainage ceased. All trials but two evaluated oral metronidazole in doses ranging from 750 mg to 800 mg three times a day over ten days. <LINK REF="STD-de-la-Rey-Nel-1989" TYPE="STUDY">de la Rey Nel 1989</LINK> et al trial administered the drug for five days and <LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK> et al trial administered the drug for a period of three weeks. Three trials administered other luminal amoebicidal drugs as co-interventions in addition to metronidazole; that is, dehydroemetine (<LINK REF="STD-Arredondo-1993" TYPE="STUDY">Arredondo 1993</LINK>), iodoquinol (<LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>), and chloroquine (<LINK REF="STD-Widjaya-1991" TYPE="STUDY">Widjaya 1991</LINK>).</P>
<P>
<B>Outcome assessment<BR/>
</B>All trials but <LINK REF="STD-Widjaya-1991" TYPE="STUDY">Widjaya 1991</LINK> measured clinical improvement in terms of fever lysis and resolution of abdominal pain as outcomes. Analysis of fever resolution was precluded in two trials due to incomplete reporting (<LINK REF="STD-Arredondo-1993" TYPE="STUDY">Arredondo 1993</LINK>; <LINK REF="STD-Blessman-2003" TYPE="STUDY">Blessman 2003</LINK>). Three trials reported clinical improvement as resolution of symptoms on a daily basis (<LINK REF="STD-de-la-Rey-Nel-1989" TYPE="STUDY">de la Rey Nel 1989</LINK>) and based on a graded scale measuring severity (<LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>). The latter two trials assessed symptom resolution as a reduction from baseline level. Data from <LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK> were reported as continuous data. One trial reported on fever lysis (<LINK REF="STD-Sharma-1989" TYPE="STUDY">Sharma 1989</LINK>), and one reported resolution of abdominal pain as proportions of patients experiencing symptom resolution (<LINK REF="STD-Blessman-2003" TYPE="STUDY">Blessman 2003</LINK>). Two trials reported the number of days to resolution of abdominal tenderness as an outcome (<LINK REF="STD-de-la-Rey-Nel-1989" TYPE="STUDY">de la Rey Nel 1989</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>), and one trial reported the proportion of patients demonstrating a reduction in liver size (<LINK REF="STD-Sharma-1989" TYPE="STUDY">Sharma 1989</LINK>). One trial evaluated radiologic resolution of the abscess size by serial ultrasonographic monitoring and reported these outcomes as proportions of patients with radiologic resolution of abscess cavities (<LINK REF="STD-Sharma-1989" TYPE="STUDY">Sharma 1989</LINK>). Three trials measured duration of hospitalisation as an outcome (<LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>; <LINK REF="STD-Arredondo-1993" TYPE="STUDY">Arredondo 1993</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>). Five of the eight trials reported adverse events (<LINK REF="STD-de-la-Rey-Nel-1989" TYPE="STUDY">de la Rey Nel 1989</LINK>; <LINK REF="STD-Sharma-1989" TYPE="STUDY">Sharma 1989</LINK>; <LINK REF="STD-Widjaya-1991" TYPE="STUDY">Widjaya 1991</LINK>; <LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>; <LINK REF="STD-Arredondo-1993" TYPE="STUDY">Arredondo 1993</LINK>), but the report was incomplete, precluding analysis.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-11-18 11:04:21 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The included trials varied in methodological quality, which in general was low (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). A description of the methodological quality of each of the included trials is given in the table of '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>'. All trials failed to report randomisation procedures in sufficient detail (and additional information was not provided). Only one trial was considered to have adequate allocation concealment (<LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>). Allocation concealment was unclear in five trials (<LINK REF="STD-de-la-Rey-Nel-1989" TYPE="STUDY">de la Rey Nel 1989</LINK>; <LINK REF="STD-Sharma-1989" TYPE="STUDY">Sharma 1989</LINK>; <LINK REF="STD-Widjaya-1991" TYPE="STUDY">Widjaya 1991</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>; <LINK REF="STD-Blessman-2003" TYPE="STUDY">Blessman 2003</LINK>). In one trial, the methodological quality was not possible to be clearly determined (<LINK REF="STD-Arredondo-1993" TYPE="STUDY">Arredondo 1993</LINK>). Blinding of outcome assessment was unclear in six trials (<LINK REF="STD-de-la-Rey-Nel-1989" TYPE="STUDY">de la Rey Nel 1989</LINK>; <LINK REF="STD-Sharma-1989" TYPE="STUDY">Sharma 1989</LINK>; <LINK REF="STD-Widjaya-1991" TYPE="STUDY">Widjaya 1991</LINK>; <LINK REF="STD-Arredondo-1993" TYPE="STUDY">Arredondo 1993</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>; <LINK REF="STD-Blessman-2003" TYPE="STUDY">Blessman 2003</LINK>) and not blinded in one trial (<LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>). All trials reported a per-protocol analysis. Four trials reported number of participants lost to follow-up (<LINK REF="STD-de-la-Rey-Nel-1989" TYPE="STUDY">de la Rey Nel 1989</LINK>; <LINK REF="STD-Sharma-1989" TYPE="STUDY">Sharma 1989</LINK>; <LINK REF="STD-Widjaya-1991" TYPE="STUDY">Widjaya 1991</LINK>; <LINK REF="STD-Blessman-2003" TYPE="STUDY">Blessman 2003</LINK>), and three trials did not specify whether there was any lost to follow-up (<LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>; <LINK REF="STD-Arredondo-1993" TYPE="STUDY">Arredondo 1993</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>). It was observed an important heterogeneity in the outcomes reported, which is an important limitation to pool the trials as their result will be highly biased.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-11-20 10:27:23 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The results of the included trials are described in the table of '<LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK>' and are described below.</P>
<P>
<B>Mortality<I>
<BR/>
</I>
</B>
<LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK> et al reported that there were no deaths. The other six trials did not report any data on deaths.</P>
<P>
<B>Proportion of patients remaining febrile<I>
<BR/>
</I>
</B>Two trials reported the number of patients remaining febrile as an outcome, with an aggregate sample size of 78 patients (aspiration plus metronidazole = 37, and metronidazole = 41) (<LINK REF="STD-Sharma-1989" TYPE="STUDY">Sharma 1989</LINK>; <LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>). The study population, methods of intervention, and outcomes measured in these two trials were similar enough in order to combine them in a meta-analysis. No statistical heterogeneity was found with a Chi square = 0.22, df = 1, P = 0.64, I<SUP>2 </SUP>= 0%. The relative risk is 0.60 (95% CI 0.22 to 1.61), showing no evidence of a statistical difference between aspiration and no aspiration <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<P>
<B>Days to resolution of fever</B>
<BR/>Two trials with an aggregate sample size of 70 patients (aspiration plus metronidazole = 35, metronidazole = 35) reported this outcome (<LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>). When data from these two trials were pooled, a statistically significant heterogeneity was noted (Chi square = 13.69, df = 1, P = 0.0002, I<SUP>2 </SUP>= 92.7%), and no statistical difference was observed <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>.</P>
<P>
<B>Proportion of patients without resolution of pain<I>
<BR/>
</I>
</B>Three trials reported this outcome with an aggregate sample size of 117 patients (metronidazole = 60, aspiration = 57) (<LINK REF="STD-Sharma-1989" TYPE="STUDY">Sharma 1989</LINK>; <LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>; <LINK REF="STD-Blessman-2003" TYPE="STUDY">Blessman 2003</LINK>). The pooled relative risk showed a tendency towards favouring aspiration 0.66 (95% CI 0.35 to 1.26) in terms of resolution of abdominal pain, although this was not found to be statistically significant. A medium level of heterogeneity was noted with a Chi square = 4.50, df = 2, P = 0.11, I<SUP>2 </SUP>= 56% <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>.</P>
<P>
<B>Days to resolution of pain</B>
<BR/>Two trials (<LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>) with an aggregate sample size of 70 patients (metronidazole = 35, aspiration = 35) reported this outcome. When data from these trials were pooled, a statistically significant heterogeneity was found (Chi square = 10.04, df = 1, P = 0.002 I<SUP>2 </SUP>= 90%), and a reduction in the number of days to resolution of pain was observed in the needle aspiration group (MD -1.59, 95% CI -2.73 to -0.42) <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>, but with the few trials available, the subgroup analyses was not performed in order to explain the heterogeneity.</P>
<P>
<B>Proportion of patients without resolution of abscess size<I>
<BR/>
</I>
</B>Two trials monitored resolution of abscess size by serial ultrasonographic monitoring with an aggregate sample size of 70 participants (metronidazole = 37, aspiration = 33) (<LINK REF="STD-Sharma-1989" TYPE="STUDY">Sharma 1989</LINK>; <LINK REF="STD-Widjaya-1991" TYPE="STUDY">Widjaya 1991</LINK>). When data for this outcome were pooled, heterogeneity was not noted (Chi square = 0.58, df = 1, P = 0.44, I<SUP>2 </SUP>= 0%). The pooled relative risk is of 0.90 (95% CI 0.62 to 1.32), showing no significant difference between needle aspiration and metronidazole alone <LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>.</P>
<P>
<B>Proportion of patients without resolution of abdominal tenderness<I>
<BR/>
</I>
</B>One trial reported this outcome with a relative risk of 0.54 (95% CI 0.19 to 1.56) with a sample size of 39 participants (aspiration plus metronidazole = 20, metronidazole = 19) (<LINK REF="STD-Blessman-2003" TYPE="STUDY">Blessman 2003</LINK>) <LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>.</P>
<P>
<B>Days to resolution of abdominal tenderness<I>
<BR/>
</I>
</B>Two trials with an aggregate sample size of 81 patients (aspiration plus metronidazole = 39, metronidazole = 42) reported this outcome (<LINK REF="STD-de-la-Rey-Nel-1989" TYPE="STUDY">de la Rey Nel 1989</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>). When data for these two trials were pooled, statistical heterogeneity was found (Chi square = 2.69, df = 1, P = 0.10, I<SUP>2 </SUP>= 62.8), and a reduction in the number of days to resolution of abdominal tenderness was observed in the needle aspiration group (MD -1.70, 95% CI -2.86 to -0.54) <LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>, but with the few trials available, the subgroup analyses was not performed in order to explain the heterogeneity.</P>
<P>
<B>Duration of hospitalisation</B>
<BR/>Three trials reported this outcome with an aggregate sample size of 92 patients (<LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK>; <LINK REF="STD-Arredondo-1993" TYPE="STUDY">Arredondo 1993</LINK>; <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK>). The results of <LINK REF="STD-Arredondo-1993" TYPE="STUDY">Arredondo 1993</LINK> and <LINK REF="STD-Tandon-1997" TYPE="STUDY">Tandon 1997</LINK> were not consistent with the <LINK REF="STD-Van-Allan-1992" TYPE="STUDY">Van Allan 1992</LINK> trial, favouring metronidazole treatment alone. When data for these three trials were pooled, a medium level of heterogeneity (Chi square = 11.32, df = 2, P = 0.003, I<SUP>2 </SUP>= 82%) was detected, and a reduction in the duration of hospitalisation was observed in the needle aspiration group (MD -1.31, 95% CI -2.05 to -0.57) <LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>, but with the few trials available, the subgroup analyses was not performed in order to explain the heterogeneity.<BR/>
</P>
<P>
<B>Adverse events </B>
<BR/>
<I>
<B>Number of patients requiring surgical intervention and rupture of abscess cavity</B>
</I>
<BR/>Two trials reported adverse events as proportion of non-responders to initial intervention (<LINK REF="STD-de-la-Rey-Nel-1989" TYPE="STUDY">de la Rey Nel 1989</LINK>; <LINK REF="STD-Arredondo-1993" TYPE="STUDY">Arredondo 1993</LINK>). When data from these two trials were meta-analysed, a statistically significant heterogeneity was noted (Chi square = 7.84, df = 1, P = 0.02, I<SUP>2</SUP> = 82%) and no difference was observed between the groups <LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>. Only in one trial, five patients underwent surgical intervention (there were no data to which group the patients belonged) (<LINK REF="STD-Widjaya-1991" TYPE="STUDY">Widjaya 1991</LINK>). Only one trial reported a single case of abscess rupture in the non-aspirated group (<LINK REF="STD-de-la-Rey-Nel-1989" TYPE="STUDY">de la Rey Nel 1989</LINK>). However, reporting in the other trials was incomplete, precluding an analysis for this outcome.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-11-18 11:38:15 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The decision to therapeutically decrease abscess size in uncomplicated amoebic liver abscess is an area of controversy and we address this issue in our review. We found no evidence that image-guided needle aspiration provides added benefits in the management of uncomplicated amoebic liver abscess. However, small study populations, inadequate methods to minimize bias, and significant heterogeneity made interpretation of pooled estimates problematic. Most of the trials included in this review were performed in the late 1980s and early 1990s in low-income countries where amoebic liver abscesses are endemic. Evidence shows that the quality of randomised clinical trials affects estimates of intervention efficacy, which is significantly exaggerated in low-quality trials. Kjaergard et al reported the association between trial quality, trial setting, and year of publication (<LINK REF="REF-Kjaergard-1999" TYPE="REFERENCE">Kjaergard 1999</LINK>). Most of the trials included in the present review failed to incorporate methodological procedures, which restrict bias. This lack of rigorousness may bias estimates of treatment effect. Inadequate sample size, unclear methods of generation of allocation sequence to ensure adequacy of randomisation, inability to conceal treatment allocation, and lack of blinding allow exaggeration of treatment efficacy when results of these high-risk bias trials are meta-analysed. To minimise bias, adequate methodological approaches in trial design, conduct, and reporting of results when assessing therapy of amoebic liver abscesses are needed to obtain robust conclusions. However, the clinical expertise and knowledge about the intrinsic limitations of statistic inferences must be another important tool to interpret the available information (<LINK REF="REF-Guller-2008" TYPE="REFERENCE">Guller 2008</LINK>).</P>
<P>In addition, significant heterogeneity has cast doubt on the robustness of conclusion drawn from these trials. Possible sources for heterogeneity in this review are variability in timing of outcome assessment, variability in definition of outcomes to be assessed, presence of co-interventions, and differences in the general quality of care received as a consequence of trial setting. Trials varied in defining the most relevant clinical outcome, ie, is it symptomatic improvement or is it radiologic resolution. Improvement in symptoms is no doubt important; however, these symptoms have to be clearly defined and timing of assessment must be uniformly evaluated.</P>
<P>Furthermore, it is equally important to study hard clinical outcomes, such as mortality and adverse events related to the treatment intervention, which can greatly influence treatment success. However, other outcomes, albeit more subjective, are more likely to be impacted upon by the experimental therapy, as observed in the analyses on resolution of pain and tenderness. Drug-related adverse events, as well as treatment-related complications as a result of invasive procedures, such as needle aspiration, were not explored in greater detail in the trials included in this review.</P>
<P>This lack of uniformity and inadequate methodological approach in clinical evaluation reflect the lack of standardisation in the therapeutic approach to amoebic liver abscesses. The creation of a diagnostic and therapeutic algorithm for amoebic liver abscesses may contribute to create this much-needed uniformity in therapy and the potential to give rise to well-designed clinical trials in the future.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-11-13 23:45:22 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2008-11-13 23:45:22 +0100" MODIFIED_BY="[Empty name]">
<P>This review found no evidence to support or refute aspiration of the abscess cavity plus metronidazole versus metronidazole alone in uncomplicated amoebic liver abscess. Trials were, however, small and lacked methodological rigour for us to be able to conclude that aspiration does or does not benefit patients. Accordingly, our findings are inconclusive to make a definite recommendation on the benefit of adjunctive therapeutic needle aspiration.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-11-09 16:50:37 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised clinical trials with larger sample sizes and adequate randomisation (generation of the allocation sequence as well as allocation concealment) and blinded outcome assessment of outcomes important to patients are urgently needed. Such trials should use uniform measures to assess outcomes.</P>
<P>Strict evaluation of adverse events resulting from different interventions employed in the management of amoebic liver abscesses should be included in future trials. Furthermore, trials ought to be reported according to the recommendations of the <A HREF="http://www.consort-statement.org/">CONSORT statement</A>.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-11-20 10:55:17 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>We recognise the valuable efforts of E Labio, R Destura, MM Alejandria, and MLO Daez who started on the preparation of the review after publishing its protocol (<LINK REF="REF-Labio-2004" TYPE="REFERENCE">Labio 2004</LINK>), but due to other obligations could not finalise it and had abandoned it before the external peer reviewing process began. Parts of the text from the abandoned version of the review were kept by the new team of authors, though they too had to undergo modifications and updates during the process of developing the present review.</P>
<P>We thank Kate Whitfield for her assistance in the search strategy and retrieval of full-text journal articles, and Dimitrinka Nikolova and Christian Gluud of The Cochrane Hepato-Biliary Group for ongoing support for this review.</P>
<P>We thank Sandra Garcia-Osogobio (Department of Surgery, Medica Sur Clinic &amp; Foundation) for her criticism and corrections.</P>
<P>We thank the CHBG Editors RL Koretz, USA; U Güller, Canada; BR Davidson, UK for the helpful comments.</P>
<P>Peer Reviewers: A Merens, France; NA Deepak, India.<BR/>Contact Editor: C Gluud, Denmark.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-11-19 15:14:59 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Norberto C Chavez-Tapia. Co-ordinating, data collection, designing search strategies, undertaking searches, screening search results, screening retrieved papers against eligibility criteria, extracting data from papers, writing to authors of papers for additional information, data management for the review, entering data into RevMan, analysis of data, writing the review.</P>
<P>Jorge Hernandez-Calleros. Data collection, undertaking searches, screening search results, screening retrieved papers against eligibility criteria, extracting data from papers.</P>
<P>Felix I Tellez-Avila. Data collection, designing search strategies, undertaking searches, screening search results, screening retrieved papers against eligibility criteria, extracting data from papers, analysis of data, writing the review.</P>
<P>Aldo Torre-Delgadillo. Interpretation of data, providing a clinical perspective, and providing general advice on the review.</P>
<P>Misael Uribe. Performing previous work that was the foundation of the current review, providing general advice, and securing funding for the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2008-11-10 11:03:08 +0100" MODIFIED_BY="[Empty name]">
<P>The protocol of this review was published with a title 'Metronidazole with or without image-guided percutaneous procedure for uncomplicated amoebic liver abscess'. We have modified it into 'Image-guided percutaneous procedure plus metronidazole <I>versus</I> metronidazole alone for uncomplicated amoebic liver abscess' for clearer wording.</P>
<P>In the excluded studies, left lobe abscesses was also considered as an exclusion criteria.</P>
<P>The Science Citation Index Expanded was included in the searching for identification methods.</P>
<P>Data analysis was performed with Review Manager Version 5.0 instead of Review Manager Version 4.2.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2008-11-09 17:14:10 +0100" MODIFIED_BY="[Empty name]">
<P>Additional information was requested to all authors by e-mail or conventional mail.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-11-20 10:55:12 +0100" MODIFIED_BY="dimitrinka nikolova">
<STUDIES MODIFIED="2008-11-09 16:38:39 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2008-11-09 16:38:39 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Arredondo-1993" MODIFIED="2008-06-13 08:18:08 +0100" MODIFIED_BY="Kate Whitfield" NAME="Arredondo 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-06-13 08:18:08 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arredondo-Cortes E, Gonzáles-Gonzáles JA, Bosques-Padilla F, Elizondo Riojas G, Barragán-Villarreal RF</AU>
<TI>A randomized controlled clinical trial of medical treatment vs medical treatment plus puncture in amoebic liver abscess</TI>
<SO>Gut</SO>
<YR>1993</YR>
<VL>34</VL>
<NO>3</NO>
<PG>S43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Blessman-2003" MODIFIED="2008-06-13 08:10:49 +0100" MODIFIED_BY="Kate Whitfield" NAME="Blessman 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-06-13 08:10:49 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blessmann J, Binh HD, Hung DM, Tannich E, Burchard G</AU>
<TI>Treatment of amoebic liver abscess with metronidazole alone or in combination with ultrasound-guided needle aspiration: a comparative, prospective and randomized study</TI>
<SO>Tropical Medicine and International Health</SO>
<YR>2003</YR>
<VL>8</VL>
<NO>11</NO>
<PG>1030-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-la-Rey-Nel-1989" MODIFIED="2008-10-31 13:54:02 +0100" MODIFIED_BY="[Empty name]" NAME="de la Rey Nel 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-06-13 08:11:18 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nel JD, Simjee AE, Patel A</AU>
<TI>Indications for aspiration of amoebic liver abscess</TI>
<SO>South African Medical Journal</SO>
<YR>1986</YR>
<VL>70</VL>
<PG>52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-31 13:54:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>de la Rey Nel J, Simjee AE, Patel A</AU>
<TI>Indications for aspiration of amoebic liver abscess</TI>
<SO>South African Medical Journal</SO>
<YR>1989</YR>
<VL>75</VL>
<NO>8</NO>
<PG>373-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sharma-1989" MODIFIED="2008-06-13 08:13:43 +0100" MODIFIED_BY="Kate Whitfield" NAME="Sharma 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-06-13 08:13:43 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharma MP, Rai RR, Acharya SK, Ray JC, Tandon BN</AU>
<TI>Needle aspiration of amoebic liver abscess</TI>
<SO>BMJ (Clinical Research Ed.)</SO>
<YR>1989</YR>
<VL>299</VL>
<PG>1308-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tandon-1997" NAME="Tandon 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tandon A, Jain AK, Dixit VK, Agarwal AK, Gupta JP</AU>
<TI>Needle aspiration in large amoebic liver abscess</TI>
<SO>Tropical Gastroenterology</SO>
<YR>1997</YR>
<VL>18</VL>
<NO>1</NO>
<PG>19-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Allan-1992" MODIFIED="2008-06-13 08:14:30 +0100" MODIFIED_BY="Kate Whitfield" NAME="Van Allan 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-06-13 08:14:30 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Allan RJ, Katz MD, Johnson MB, Laine LA, Liu Y, Ralls PW</AU>
<TI>Uncomplicated amebic liver abscess: prospective evaluation of percutaneous therapeutic aspiration</TI>
<SO>Radiology</SO>
<YR>1992</YR>
<VL>183</VL>
<NO>3</NO>
<PG>827-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Widjaya-1991" MODIFIED="2008-06-13 08:18:33 +0100" MODIFIED_BY="Kate Whitfield" NAME="Widjaya 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-06-13 08:18:33 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Widjaya P, Bilic A, Babic Z, Ljubicic N, Bakula B, Pilas V</AU>
<TI>Amoebic liver abscess: ultrasonographic characteristics and results of different therapeutic approaches</TI>
<SO>Acta Medica Iugoslavica</SO>
<YR>1991</YR>
<VL>45</VL>
<NO>1</NO>
<PG>15-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-11-09 16:38:38 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bhatia-1998" NAME="Bhatia 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bhatia S, Karnad DR, Oak JL</AU>
<TI>Randomized double-blind trial of metronidazole versus secnidazole in amebic liver abscess</TI>
<SO>Indian Journal of Gastroenterology</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>2</NO>
<PG>53-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cervantes-1974" MODIFIED="2008-06-13 08:19:09 +0100" MODIFIED_BY="Kate Whitfield" NAME="Cervantes 1974" YEAR="1974">
<REFERENCE MODIFIED="2008-06-13 08:19:09 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cervantes LF, Gonzalez Montesinos F, Gordon F, Castro L</AU>
<TI>Are estrogens useful in the treatment of amebic liver abscess?</TI>
<SO>Archicos de Investigación Médica</SO>
<YR>1974</YR>
<VL>5</VL>
<NO>Suppl 2</NO>
<PG>541-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cohen-1975" NAME="Cohen 1975" YEAR="1975">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cohen HG, Reynolds TB</AU>
<TI>Comparison of metronidazole and chloroquine for the treatment of amoebic liver abscess</TI>
<SO>Gastroenterology</SO>
<YR>1975</YR>
<VL>69</VL>
<NO>1</NO>
<PG>35-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Datta-1974" MODIFIED="2008-06-17 11:17:15 +0100" MODIFIED_BY="[Empty name]" NAME="Datta 1974" YEAR="1974">
<REFERENCE MODIFIED="2008-06-17 11:17:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Datta DV, Singh SA, Chhuttani PN</AU>
<TI>Treatment of amebic liver abscess with emetine hydrochloride, niridazole, and metronidazole. A controlled clinical trial</TI>
<SO>American Journal of Tropical Medicine and Hygiene</SO>
<YR>1974</YR>
<VL>23</VL>
<NO>4</NO>
<PG>586-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Esquivel-Lopez-1979" MODIFIED="2008-06-13 08:20:20 +0100" MODIFIED_BY="Kate Whitfield" NAME="Esquivel Lopez 1979" YEAR="1979">
<REFERENCE MODIFIED="2008-06-13 08:20:20 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Esquivel López A, González Espínola G, García Garduño JR, Guarner Dalias V</AU>
<TI>Various considerations in the treatment of amebic liver abscess</TI>
<SO>Revista de Gastroenterologia de Mexico</SO>
<YR>1979</YR>
<VL>44</VL>
<NO>2</NO>
<PG>51-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Filice-1992" MODIFIED="2008-10-31 13:55:42 +0100" MODIFIED_BY="[Empty name]" NAME="Filice 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-10-31 13:55:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Filice C, Di Perri G, Stroselli M, Brunetti E, Dughetti S, van Thiel DH, et al</AU>
<TI>Outcome of hepatic amebic abscesses managed with three different therapeutic strategies</TI>
<SO>Digestive Diseases and Sciences</SO>
<YR>1992</YR>
<VL>37</VL>
<NO>2</NO>
<PG>240-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Freeman-1990" MODIFIED="2008-11-09 16:38:38 +0100" MODIFIED_BY="[Empty name]" NAME="Freeman 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-11-09 16:38:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Freeman O, Akamaguna A, Jarikre LN</AU>
<TI>Amoebic liver abscess: the effect of aspiration on the resolution or healing time</TI>
<SO>Annals of Tropical Medicine and Parasitology</SO>
<YR>1990</YR>
<VL>84</VL>
<NO>3</NO>
<PG>281-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Genadieva-1997" MODIFIED="2008-06-13 08:21:24 +0100" MODIFIED_BY="Kate Whitfield" NAME="Genadieva 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-06-13 08:21:24 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Genadieva-Dimitrova M, Neskovski M, Serafimoski V, Zografski GJ</AU>
<TI>Fine needle aspiration biopsy of diffuse liver lesions</TI>
<SO>Gut</SO>
<YR>1997</YR>
<VL>45</VL>
<NO>Suppl 5</NO>
<PG>A223</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hatchuel-1975" NAME="Hatchuel 1975" YEAR="1975">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hatchuel W</AU>
<TI>Tinidazole for the treatment of amoebic liver abscess</TI>
<SO>South African Medical Journal</SO>
<YR>1975</YR>
<VL>49</VL>
<NO>45</NO>
<PG>1879-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Irusen-1992" NAME="Irusen 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Irusen EM, Jackson TF, Simjee AE</AU>
<TI>Asymptomatic intestinal colonization by pathogenic Entamoeba histolytica in amebic liver abscess: prevalence, response to therapy, and pathogenic potential</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>1992</YR>
<VL>14</VL>
<NO>4</NO>
<PG>889-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Islam-1978" NAME="Islam 1978" YEAR="1978">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Islam N, Hasan M</AU>
<TI>Tinidazole and metronidazole in hepatic amoebiasis</TI>
<SO>Journal of Tropical Medicine and Hygiene</SO>
<YR>1978</YR>
<VL>81</VL>
<NO>1</NO>
<PG>20-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jain-1990" NAME="Jain 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jain NK, Madan A, Sharma TN, Sharma DK, Mandhana RG</AU>
<TI>Hepatopulmonary amoebiasis. Efficacy of various treatment regimens containing dehydroemetine and/or metronidazole</TI>
<SO>Journal of the Association of Physicians of India</SO>
<YR>1990</YR>
<VL>38</VL>
<NO>4</NO>
<PG>269-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jayawickrema-1975" MODIFIED="2008-06-13 08:22:11 +0100" MODIFIED_BY="Kate Whitfield" NAME="Jayawickrema 1975" YEAR="1975">
<REFERENCE MODIFIED="2008-06-13 08:22:11 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jayawickrema US, Lionel ND</AU>
<TI>Comparison of metronidazole with emetine and chloroquine in the treatment of hepatic amoebiasis- A controlled double blind study</TI>
<SO>Ceylon Medical Journal</SO>
<YR>1975</YR>
<VL>20</VL>
<NO>2</NO>
<PG>99-102</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khokhani-1977" MODIFIED="2008-06-13 08:22:28 +0100" MODIFIED_BY="Kate Whitfield" NAME="Khokhani 1977" YEAR="1977">
<REFERENCE MODIFIED="2008-06-13 08:22:28 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khokhani RC, Garud AD, Deodhar KP, Sureka SB, Kulkarni M, Damle VB</AU>
<TI>Comparative study of tinidazole and metronidazole in amoebic liver abscess</TI>
<SO>Current Medical Research and Opinion</SO>
<YR>1977</YR>
<VL>5</VL>
<NO>2</NO>
<PG>161-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khokhani-1978" NAME="Khokhani 1978" YEAR="1978">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khokhani RC, Garud AD, Deodhar KP, Sureka SB, Kulkarni M, Damle VB</AU>
<TI>Treatment of amoebic liver abscess with tinidazole and metronidazole</TI>
<SO>Drugs</SO>
<YR>1978</YR>
<VL>15</VL>
<NO>Suppl 1</NO>
<PG>23-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lasserre-1983" MODIFIED="2008-06-13 08:22:49 +0100" MODIFIED_BY="Kate Whitfield" NAME="Lasserre 1983" YEAR="1983">
<REFERENCE MODIFIED="2008-06-13 08:22:49 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lasserre R, Jaroonvesama N, Kurathong S, Soh CT</AU>
<TI>Single-day drug treatment of amebic liver abscess</TI>
<SO>American Journal of Tropical Medicine and Hygiene</SO>
<YR>1983</YR>
<VL>32</VL>
<NO>4</NO>
<PG>723-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mogollon-1999" MODIFIED="2008-06-17 11:18:55 +0100" MODIFIED_BY="[Empty name]" NAME="Mogollon 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-06-17 11:18:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mogollón Prado A, Molina Sánchez G, Martínez Macías F, Sánchez Villanueva P, Sánchez Trejo S, Dávila Fernández BC, et al</AU>
<TI>Percutaneous drainage of amebic hepatic abscess by guided ultrasound. Preliminary results</TI>
<SO>Revista de Gastroenterologia Mexico</SO>
<YR>1999</YR>
<VL>64</VL>
<NO>3</NO>
<PG>134-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morales-1975" NAME="Morales 1975" YEAR="1975">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morales MP, Suarez SF, Boom RA</AU>
<TI>Random double blind comparison of intravenous metronidazole and intramuscular emetine in acute amebic liver abscess.</TI>
<TO>Tratamiento doble ciego al azar con metronidazol I.V. o emetina I.M. en el absceso hepatico amibiano agudo</TO>
<SO>Prenmedmex</SO>
<YR>1975</YR>
<VL>40</VL>
<NO>3-4</NO>
<PG>124-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-N_x0027_Gbesso-1993" NAME="N'Gbesso 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>N'Gbesso R, Keita K, Djedje AT</AU>
<TI>Criteria of indication of puncture of amebic liver abscesses. 228 patients</TI>
<SO>Journal de Radiologie</SO>
<YR>1993</YR>
<VL>74</VL>
<PG>575-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Powell-1965" MODIFIED="2008-06-13 08:24:52 +0100" MODIFIED_BY="Kate Whitfield" NAME="Powell 1965" YEAR="1965">
<REFERENCE MODIFIED="2008-06-13 08:24:52 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powell SJ, Wilmot AJ, Macleod IN, Elson-Dew R</AU>
<TI>Dehydroemetine in the treatment of amoebic liver abscess</TI>
<SO>Annals of Tropical Medicine and Parasitology</SO>
<YR>1965</YR>
<VL>59</VL>
<PG>208-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Powell-1967" MODIFIED="2008-06-13 08:25:13 +0100" MODIFIED_BY="Kate Whitfield" NAME="Powell 1967" YEAR="1967">
<REFERENCE MODIFIED="2008-06-13 08:25:13 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powell SJ, Wilmot AJ, Macleod IN, Elsdon-Dew R</AU>
<TI>A comparative trial of dehydroemetine ad emetine hydrochloride in identical dosage in amoebic liver abscess</TI>
<SO>Annals of Tropical Medicine and Parasitology</SO>
<YR>1967</YR>
<VL>61</VL>
<NO>1</NO>
<PG>26-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Powell-1974" MODIFIED="2008-06-13 08:25:39 +0100" MODIFIED_BY="Kate Whitfield" NAME="Powell 1974" YEAR="1974">
<REFERENCE MODIFIED="2008-06-13 08:25:39 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powell SJ, Rubidge CJ, Elsdon-Dew R</AU>
<TI>Clinical trials of benzoyl metronidazole suspension in amoebic dysentery and amoebic liver abscess</TI>
<SO>South African Medical Journal</SO>
<YR>1974</YR>
<VL>47</VL>
<NO>12</NO>
<PG>507-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rajak-1998" MODIFIED="2008-06-13 08:25:48 +0100" MODIFIED_BY="Kate Whitfield" NAME="Rajak 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-06-13 08:25:48 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rajak CL, Gupta S, Jain S, Chawla Y, Gulati M, Suri S</AU>
<TI>Percutaneous treatment of liver abscesses: needle aspiration versus catheter drainage</TI>
<SO>American Journal of Roentgenology</SO>
<YR>1998</YR>
<VL>170</VL>
<NO>4</NO>
<PG>1035-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramani-1993" NAME="Ramani 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ramani A, Ramani R, Kumar MS, Lakhkar BN, Kundaje GN</AU>
<TI>Ultrasound-guided needle aspiration of amoebic liver abscess</TI>
<SO>Postgraduate Medical Journal</SO>
<YR>1993</YR>
<VL>69</VL>
<PG>381-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ruas-1973" NAME="Ruas 1973" YEAR="1973">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ruas A, Correia MH, Valle JC, Ribeiro JA</AU>
<TI>Comparative study of the effects of RO 7-0207 in amoebic liver abscess</TI>
<SO>Central Africa Journal of Medicine</SO>
<YR>1973</YR>
<VL>19</VL>
<NO>6</NO>
<PG>128-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Satpathy-1988" NAME="Satpathy 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Satpathy BK, Acharya SK, Satpathy S</AU>
<TI>Comparative study of intravenous metronidazole and intramuscular dehydroemetine in amoebic liver abscess</TI>
<SO>Journal of the Indian Medical Association</SO>
<YR>1988</YR>
<VL>86</VL>
<NO>2</NO>
<PG>38-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simjee-1985" MODIFIED="2008-06-13 08:26:19 +0100" MODIFIED_BY="Kate Whitfield" NAME="Simjee 1985" YEAR="1985">
<REFERENCE MODIFIED="2008-06-13 08:26:19 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simjee AE, Gathiram V, Jackson TF, Khan BF</AU>
<TI>A comparative trial of metronidazole versus tinidazole in the treatment of amoebic liver abscess</TI>
<SO>South African Medical Journal</SO>
<YR>1985</YR>
<VL>68</VL>
<NO>13</NO>
<PG>923-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Singh-1989" NAME="Singh 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Singh JP, Kashyap A</AU>
<TI>A comparative evaluation of percutaneous catheter drainage for resistant amebic liver abscesses</TI>
<SO>American Journal of Surgery</SO>
<YR>1989</YR>
<VL>158</VL>
<NO>1</NO>
<PG>58-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Soh-1980" NAME="Soh 1980" YEAR="1980">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Soh CT, Cho MJ, Choi HJ, Hur JD</AU>
<TI>Double blind test of ornidazole versus tinidazole against amoebic liver abscess</TI>
<SO>Yonsei Reports on Tropical Medicine</SO>
<YR>1980</YR>
<VL>11</VL>
<NO>1</NO>
<PG>43-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yu-2004" MODIFIED="2008-06-13 08:26:49 +0100" MODIFIED_BY="Kate Whitfield" NAME="Yu 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-06-13 08:26:49 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yu SC, Ho SS, Lau WY, Yeung DT, Yuen EH, Lee PS, et al</AU>
<TI>Treatment of pyogenic liver abscess: prospective randomized comparison of catheter drainage and needle aspiration</TI>
<SO>Hepatology</SO>
<YR>2004</YR>
<VL>39</VL>
<NO>4</NO>
<PG>932-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zafar-2002" MODIFIED="2008-06-13 08:27:18 +0100" MODIFIED_BY="Kate Whitfield" NAME="Zafar 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-06-13 08:27:18 +0100" MODIFIED_BY="Kate Whitfield" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zafar A, Ahmed S</AU>
<TI>Amoebic liver abscess: a comparative study of needle aspiration versus conservative treatment</TI>
<SO>Journal of Ayub Medical College Abbottabad</SO>
<YR>2002</YR>
<VL>14</VL>
<NO>1</NO>
<PG>10-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-11-20 10:55:12 +0100" MODIFIED_BY="dimitrinka nikolova">
<ADDITIONAL_REFERENCES MODIFIED="2008-11-20 10:55:12 +0100" MODIFIED_BY="dimitrinka nikolova">
<REFERENCE ID="REF-Giorgio-1995" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Giorgio 1995" TYPE="JOURNAL_ARTICLE">
<AU>Giorgio A, Tarantino L, Mariniello N, Francica G, Scala E, Amoroso P, et al</AU>
<TI>Pyogenic liver abscesses: 13 years of experience in percutaneous needle aspiration with US guidance</TI>
<SO>Radiology</SO>
<YR>1995</YR>
<VL>195</VL>
<PG>122-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gluud-2001" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Gluud 2001" TYPE="OTHER">
<AU>Gluud C</AU>
<TI>Alcoholic hepatitis: no glucocorticosteroids?</TI>
<SO>FALK Symposium 121. Steatohepatitis (NASH and ASH)</SO>
<YR>2001</YR>
<PG>322-42</PG>
<ED>Leuschner U, James OFW, Dancygier H</ED>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gluud-2008" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Gluud 2008" TYPE="OTHER">
<AU>Gluud C, Nikolova D, Klingenberg SL, Whitfield K, Alexakis N, Als-Nielsen B, et al</AU>
<TI>Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs))</TI>
<SO>2008, Issue 4. Art. No.: LIVER</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guller-2008" MODIFIED="2008-11-18 11:40:14 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Guller 2008" TYPE="JOURNAL_ARTICLE">
<AU>Guller U</AU>
<TI>Caveats in the interpretation of the surgical literature</TI>
<SO>The British Journal of Surgery</SO>
<YR>2008</YR>
<VL>95</VL>
<NO>5</NO>
<PG>541-546</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haque-2003" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Haque 2003" TYPE="JOURNAL_ARTICLE">
<AU>Haque R, Huston CH, Hughes M, Houpt E, Petri W</AU>
<TI>Current concepts Amebiasis</TI>
<SO>New England Journal of Medicine</SO>
<YR>2003</YR>
<VL>348</VL>
<NO>16</NO>
<PG>1565-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Higgins 2008" TYPE="BOOK">
<AU>Higgins JPT, Green S (editors)</AU>
<SO>Cochrane Handbook for Systematic Reviews of Intervention 5.0.0 [updated February 2008]</SO>
<YR>2008. Available from www.cochrane-handbook.org</YR>
<PB>The Cochrane Colloboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hughes-2000" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Hughes 2000" TYPE="JOURNAL_ARTICLE">
<AU>Hughes MA, Petri WA</AU>
<TI>Amebic Liver Abscess</TI>
<SO>Infectious Disease Clinics of North America</SO>
<YR>2000</YR>
<VL>14</VL>
<NO>3</NO>
<PG>565-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kjaergard-1999" MODIFIED="2008-11-18 11:40:14 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Kjaergard 1999" TYPE="JOURNAL_ARTICLE">
<AU>Kjaergard LL, Nikolova D, Gluud C</AU>
<TI>Randomized clinical trials in HEPATOLOGY: predictors of quality</TI>
<SO>Hepatology</SO>
<YR>1999</YR>
<VL>30</VL>
<NO>5</NO>
<PG>1134-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kjaergard-2001" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Kjaergard 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kjaergard LL, Villumsen J, Gluud C</AU>
<TI>Reported methodological quality and discrepancies between large and small randomised trials in meta-analyses</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2001</YR>
<VL>135</VL>
<NO>11</NO>
<PG>982-9</PG>
<IDENTIFIERS MODIFIED="2008-06-13 08:37:24 +0100" MODIFIED_BY="Kate Whitfield"/>
</REFERENCE>
<REFERENCE ID="REF-Labio-2004" MODIFIED="2008-11-20 10:55:12 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Labio 2004" TYPE="COCHRANE_PROTOCOL">
<AU>Labio E, Destura R, Alejandria MM, Daez MLO</AU>
<TI>Metronidazole with or without image-guided percutaneous procedure for uncomplicated amoebic liver abscess</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2008-11-20 10:52:27 +0100" MODIFIED_BY="dimitrinka nikolova">
<IDENTIFIER MODIFIED="2008-11-20 10:52:27 +0100" MODIFIED_BY="dimitrinka nikolova" TYPE="DOI" VALUE="10.1002/14651858.CD004886"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Moher-1998" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Moher 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al</AU>
<TI>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>352</VL>
<NO>9128</NO>
<PG>609-13</PG>
<IDENTIFIERS MODIFIED="2008-06-13 08:37:36 +0100" MODIFIED_BY="Kate Whitfield"/>
</REFERENCE>
<REFERENCE ID="REF-Petri-1999" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Petri 1999" TYPE="JOURNAL_ARTICLE">
<AU>Petri WA Jr, Singh U</AU>
<TI>Diagnosis and Management of Amebiasis</TI>
<SO>Clinical infectious diseases</SO>
<YR>1999</YR>
<VL>29</VL>
<PG>1117-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ravdin-1995" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Ravdin 1995" TYPE="JOURNAL_ARTICLE">
<AU>Ravdin JI</AU>
<TI>Amoebiasis</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>1995</YR>
<VL>20</VL>
<PG>1453-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reed-1992" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Reed 1992" TYPE="JOURNAL_ARTICLE">
<AU>Reed SL</AU>
<TI>Amoebiasis: an update</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>1992</YR>
<VL>14</VL>
<PG>385-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reed-1998" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Reed 1998" TYPE="BOOK_SECTION">
<AU>Reed SL</AU>
<TI>Amoebiasis and infection with free-living amoebas</TI>
<SO>Harrison's Principles of Internal Medicine</SO>
<YR>1998</YR>
<PG>1176-80</PG>
<EN>14th</EN>
<PB>McGraw Hill Inc</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2008" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="RevMan 2008" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2008</YR>
<EN>5.0 for Windows</EN>
<PB>Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Royle-2003" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Royle 2003" TYPE="JOURNAL_ARTICLE">
<AU>Royle P, Milne R</AU>
<TI>Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches</TI>
<SO>International Journal of Technology Assessment in Health Care</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>4</NO>
<PG>591-603</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ruiz_x002d_Palacios-1997" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Ruiz-Palacios 1997" TYPE="JOURNAL_ARTICLE">
<AU>Ruiz-Palacios G</AU>
<TI>Amoebiasis</TI>
<SO>Medicine International</SO>
<YR>1997</YR>
<VL>11</VL>
<PG>46-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayer R, Altman D</AU>
<TI>Empirical evidence of bias</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1995</YR>
<VL>273</VL>
<NO>5</NO>
<PG>408-12</PG>
<IDENTIFIERS MODIFIED="2008-06-13 08:44:06 +0100" MODIFIED_BY="Kate Whitfield"/>
</REFERENCE>
<REFERENCE ID="REF-Sharma-1996" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Sharma 1996" TYPE="JOURNAL_ARTICLE">
<AU>Sharma MP, Dasarathy S, Verma N, Saksena S, Shukla DK</AU>
<TI>Prognostic markers in amoebic liver abscess: a prospective study</TI>
<SO>American Journal of Gastroenterology</SO>
<YR>1996</YR>
<VL>91</VL>
<PG>2584-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stanley-2003" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Stanley 2003" TYPE="JOURNAL_ARTICLE">
<AU>Stanley SL</AU>
<TI>Amoebiasis</TI>
<SO>Lancet</SO>
<YR>2003</YR>
<VL>361</VL>
<PG>1025-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wood-2008" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Wood 2008" TYPE="JOURNAL_ARTICLE">
<AU>Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al</AU>
<TI>Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study</TI>
<SO>BMJ (Clinical Research Ed.)</SO>
<YR>2008</YR>
<VL>336</VL>
<PG>601-5</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2008-10-31 14:09:08 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Nel-JD-1985" NAME="Nel JD 1985" TYPE="JOURNAL_ARTICLE">
<AU>Nel JD, Patel A, Ramdial K, Simjee AE, Engelbrecht HE, Dingle C and Anderson CB</AU>
<TI>Does aspiration influence the course of amoebic liver abscess?</TI>
<SO>SAMT DEEL</SO>
<YR>1985</YR>
<VL>68</VL>
<PG>528</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Payawal-1994" NAME="Payawal 1994" TYPE="JOURNAL_ARTICLE">
<AU>Alcantara-Payawal DE, Sollano JD, Lim VY, Alvarez SZ, Perez JYJr</AU>
<TI>Sequential medical treatment with needle aspiration on large amebic liver abscess: is it advantageous?</TI>
<SO>Journal of Gastroenterology and Hepatology</SO>
<YR>1994</YR>
<VL>9</VL>
<NO>3</NO>
<PG>A50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Perez-1978" NAME="Perez 1978" TYPE="JOURNAL_ARTICLE">
<AU>Perez JY Jr</AU>
<TI>The management of amoebic hepatic abscess</TI>
<SO>Drugs</SO>
<YR>1978</YR>
<VL>15 Suppl 1</VL>
<PG>49-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weinke-2002" NAME="Weinke 2002" TYPE="JOURNAL_ARTICLE">
<AU>Weinke T, Grobusch MP, Guthoff W</AU>
<TI>Amebic liver abscess - rare need for percutaneous treatment modalities</TI>
<SO>European Journal of Medical Research</SO>
<YR>2002</YR>
<VL>7</VL>
<PG>25-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yeoh-1996" NAME="Yeoh 1996" TYPE="JOURNAL_ARTICLE">
<AU>Yeoh KG, Yap I, Wong ST et al</AU>
<TI>Tropical liver abscess</TI>
<SO>Postgraduate Medical Journal</SO>
<YR>1996</YR>
<VL>73</VL>
<PG>89-92</PG>
<IDENTIFIERS/>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-11-18 11:34:27 +0100" MODIFIED_BY="dimitrinka nikolova">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-11-18 11:34:27 +0100" MODIFIED_BY="dimitrinka nikolova" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-10-21 03:25:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Arredondo-1993">
<CHAR_METHODS MODIFIED="2000-01-01 05:45:52 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised trial.</P>
<P>Generation of the allocation sequence: Unclear. No information provided.</P>
<P>Allocation concealment: Unclear. No information provided.</P>
<P>Blinding: Unclear. No information provided.</P>
<P>ITT analysis: No.</P>
<P>Follow-up: No information provided.</P>
<P>Sample size calculation: No information provided.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: Mexico.</P>
<P>Number of participants randomised: 22.</P>
<P>Inclusion criteria: Right upper quadrant abdominal pain, fever, increased white blood counts, and suggesting image by ultrasound.</P>
<P>Exclusion criteria: Pleuropulmonary and pericardial complications, sever liver failure, abdominal guarding, shock or previous medical therapy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2000-01-01 05:45:50 +0100" MODIFIED_BY="[Empty name]">
<P>Experimental: US guided aspiration plus metronidazole 750 mg TID, and dehydroemetine 1-1.5 mg/kg/day.</P>
<P>Control: Metronidazole 750 mg TID, and dehydroemetine 1 to 1.5 mg/kg/day.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-21 03:25:42 +0100" MODIFIED_BY="[Empty name]">
<P>Fever, white blood count, pain, hospitalisation time.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Data obtained from abstract.<BR/>The authors were not able to send the complete manuscript, to include all data.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 19:23:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Blessman-2003">
<CHAR_METHODS MODIFIED="2008-11-09 19:23:41 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised trial.</P>
<P>Generation of the allocation sequence: Unclear. No information provided.</P>
<P>Allocation concealment: Unclear. No information provided.</P>
<P>Blinding: Unclear. No information provided.</P>
<P>ITT analysis: No information provided.</P>
<P>Follow-up: 28 days after discharge, all patients were re-examined at the end of the follow-up period.</P>
<P>Sample size calculation: No information provided.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2000-01-01 05:44:55 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Vietnam</P>
<P>Number of participants randomised: 39.</P>
<P>Inclusion criteria: Abscess with a diameter of 6 cm to 10 cm; abscess localisation in the right liver lobe, except the caudate lobe; age &gt;18 years.</P>
<P>Exclusion criteria: Treatment with amoebicidal drugs before hospital admission, pregnancy, or presence of aerobic or anaerobic bacteria in the abscess fluid.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2000-01-01 05:44:57 +0100" MODIFIED_BY="[Empty name]">
<P>Experimental: Fine needle US guided aspiration plus metronidazole 30 mg/kg TID for 10 days.</P>
<P>Control: Metronidazole 30 mg/kg TID for 10 days.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-21 03:26:29 +0100" MODIFIED_BY="[Empty name]">
<P>Body temperature, pain and tenderness in right upper abdomen, leucocyte count, erythrocyte sedimentation rate, haemoglobin, and C-reactive protein and abscess volume.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 19:28:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-de-la-Rey-Nel-1989">
<CHAR_METHODS MODIFIED="2008-11-09 19:28:59 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised trial.</P>
<P>Generation of the allocation sequence: Unclear.</P>
<P>Allocation concealment: Unclear. No information provided.</P>
<P>Blinding: No information provided.</P>
<P>ITT analysis: No information provided.</P>
<P>Follow-up: Monthly until complete resolution of the cavity, all patients were re-examined at the end of the follow-up period.</P>
<P>Sample size calculation: No information provided.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-04-14 11:55:32 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Country: South Africa.</P>
<P>Number of participants randomised: 80.</P>
<P>Inclusion criteria: Liver abscess by ultrasound and positive amoebiasis gel diffusion test.</P>
<P>Exclusion criteria: Refuse to be hospitalised, liver abscess located in the superior half of the left lobule.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2000-01-01 05:44:58 +0100" MODIFIED_BY="[Empty name]">
<P>Experimental: US guided aspiration plus metronidazole 800 mg TID for 5 days.</P>
<P>Control: Metronidazole 800 mg TID for 5 days.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Body temperature, tenderness, liver size, and size of abscess cavity.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 19:30:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sharma-1989">
<CHAR_METHODS MODIFIED="2008-11-09 19:30:29 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised case-control trial.</P>
<P>Generation of the allocation sequence: No information provided.</P>
<P>Allocation concealment: No information provided.</P>
<P>Blinding: Unclear.</P>
<P>ITT analysis: No.</P>
<P>Follow-up: 12 months, all patients were re-examined at the end of the follow-up period.</P>
<P>Sample size calculation: No information provided.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-23 09:34:04 +0100" MODIFIED_BY="[Empty name]">
<P>Country: India.</P>
<P>Number of participants randomised: 39.</P>
<P>Inclusion criteria: Positive serological results for <I>E histolytica</I> (ELISA and indirect hemagglutination), one or more lesions occupying space in the right lobe of the liver with characteristic features of amoebic liver abscess on ultrasound examination.</P>
<P>Exclusion criteria: Abscess in the left lobe, multiple liver abscesses, and impending rupture.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-23 09:34:21 +0100" MODIFIED_BY="[Empty name]">
<P>Experimental: Needle aspiration plus metronidazole 2.4 g at day for 10 days.</P>
<P>Control: Metronidazole 2.4 g at day for 10 days.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Abdominal pain, fever, anorexia, and hepatomegaly.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-18 11:34:27 +0100" MODIFIED_BY="dimitrinka nikolova" STUDY_ID="STD-Tandon-1997">
<CHAR_METHODS MODIFIED="2008-10-23 09:34:41 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised trial.</P>
<P>Generation of the allocation sequence: Unclear. No information provided.</P>
<P>Allocation concealment: Unclear. No information provided.</P>
<P>Blinding: Patient and provider not blinded.</P>
<P>ITT analysis: No information provided.</P>
<P>Follow-up: No information provided.</P>
<P>Sample size calculation: No information provided.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: India.</P>
<P>Number of participants randomised: 29.</P>
<P>Inclusion criteria: uncomplicated, amoebic liver abscess larger than 5 cm. </P>
<P>Exclusion criteria: No information provided.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-06-13 08:04:37 +0100" MODIFIED_BY="Kate Whitfield">
<P>Experimental: Needle aspiration plus metronidazole 800 mg TID for 10 days.</P>
<P>Control: metronidazole alone.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Resolution of fever, pain, duration of hospital stay.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-18 11:34:27 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Data obtained from abstract.<BR/>The authors were not able to send the complete manuscript, to include all data. Not information about dose in control group was provided.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 19:41:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Van-Allan-1992">
<CHAR_METHODS MODIFIED="2008-11-09 19:41:44 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised trial.</P>
<P>Generation of the allocation sequence: Unclear.</P>
<P>Allocation concealment: Adequate. Using sealed envelopes.</P>
<P>Blinding: No.</P>
<P>ITT analysis: No.</P>
<P>Follow-up: No information provided.</P>
<P>Sample size calculation: No information provided.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: United States.</P>
<P>Number of participants randomised: 41.</P>
<P>Inclusion criteria: Abscess at least 5 cm in diameter (US or CT), and/or abscess less than 5 cm in diameter accompanied by moderate or severe pain, and/or abscess less than 5 cm in diameter accompanied by fever (&gt;102°F).</P>
<P>Exclusion criteria: Inability to obtain informed consent, rupture at the time of diagnosis, contraindication to one or both of the therapeutic regimens, or identification of patients more than 24 hours after initiation of therapy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2000-01-01 05:45:13 +0100" MODIFIED_BY="[Empty name]">
<P>Experimental: US or CT guided needle aspiration plus metronidazole 750 mg TID +/- iodoquinol for 10 to 14 days.</P>
<P>Control: Metronidazole 750 mg TID +/- iodoquinol for 10 to 14 days.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-04-14 11:56:14 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Temperature, pain, tenderness, and length of hospitalisation.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 20:37:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Widjaya-1991">
<CHAR_METHODS MODIFIED="2008-11-09 20:37:36 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised trial.</P>
<P>Generation of the allocation sequence: Unclear.</P>
<P>Allocation concealment: Unclear.</P>
<P>Blinding: Unclear.</P>
<P>ITT analysis: No.</P>
<P>Follow-up: Until resolution of abscesses, all patients were re-examined at the end of the follow-up period.</P>
<P>Sample size calculation: No information provided.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: Indonesia.</P>
<P>Number of participants randomised: 60.</P>
<P>Inclusion criteria: Symptoms and signs, positive indirect hemagglutination test and suggestive ultrasound findings.</P>
<P>Exclusion criteria: No information provided.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Experimental: Metronidazole 750 mg TID, and chloroquine (500 mg BID the first day, after 500 mg) for 10 days plus US guided aspiration.</P>
<P>Control: Metronidazole 750 mg TID, and chloroquine (500 mg BID the first day, after 500 mg at day) for 10 days.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Resolution of abscess.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-15 21:02:08 +0100" MODIFIED_BY="[Empty name]">
<P>A clear definition of "resolution of abscess" was not provided.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ITT = intention to treat<BR/>US = ultrasound<BR/>BID = twice-daily dosage <BR/>TID = thrice-daily dosage<BR/>CT = computed tomography</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-11-10 11:03:20 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2008-11-10 11:03:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bhatia-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-10 11:03:12 +0100" MODIFIED_BY="[Empty name]">
<P>A randomised trial comparing metronidazole <I>versus</I> secnidazole in 32 patients with amoebic liver abscess. There was no comparison made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cervantes-1974">
<CHAR_REASON_FOR_EXCLUSION>
<P>A clinical trial evaluating the use of estrogens in the treatment of amoebic liver abscess.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cohen-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>A randomised trial including 36 patients with amoebic liver abscess comparing metronidazole and chloroquine for the treatment of amoebic liver abscess. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Datta-1974">
<CHAR_REASON_FOR_EXCLUSION>
<P>A controlled clinical trial comparing emetine hydrochloride, niridazole, and metronidazole in the treatment of amoebic liver abscess. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Esquivel-Lopez-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>This study is non-randomised. Sixty patients with complicated amoebic liver abscesses failing medical therapy received different pharmacologic interventions. No comparison made with percutaneous procedures.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-13 08:05:30 +0100" MODIFIED_BY="Kate Whitfield" STUDY_ID="STD-Filice-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-13 08:05:30 +0100" MODIFIED_BY="Kate Whitfield">
<P>This study is a retrospective observational study of 51 patients with amoebic liver abscess comparing medical therapy with nitroimidazole, open surgical drainage, and percutaneous drainage followed by intralesional nitroimidazole administration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-09 16:52:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Freeman-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-09 16:52:21 +0100" MODIFIED_BY="[Empty name]">
<P>This study is quasi randomised, without information about adverse events.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-15 20:53:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Genadieva-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-15 20:53:20 +0100" MODIFIED_BY="[Empty name]">
<P>A clinical study examining fine needle aspiration biopsy of diffuse liver lesions including non-amoebic hepatic lesions. No comparison was made with medical therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hatchuel-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>A randomised, double blind trial comparing tinidazole with metronidazole in 14 patients with amoebic liver abscess. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-13 08:09:09 +0100" MODIFIED_BY="Kate Whitfield" STUDY_ID="STD-Irusen-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-13 08:09:09 +0100" MODIFIED_BY="Kate Whitfield">
<P>A prospective cohort study investigating the prevalence and natural history of asymptomatic intestinal colonisation in 50 patients with amoebic liver abscess.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2000-01-01 05:45:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Islam-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2000-01-01 05:45:16 +0100" MODIFIED_BY="[Empty name]">
<P>A randomised trial comparing two medical treatment, tinidazole and metronidazole, in 31 patients with hepatic amoebiasis. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-13 08:05:34 +0100" MODIFIED_BY="Kate Whitfield" STUDY_ID="STD-Jain-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-13 08:05:34 +0100" MODIFIED_BY="Kate Whitfield">
<P>A study of 33 patients with hepatopulmonary amoebiasis which compared the efficacy of dehydroemetine and metronidazole. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jayawickrema-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>A randomised trial comparing metronidazole with emetine and chloroquine in the treatment of hepatic amoebiasis. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Khokhani-1977">
<CHAR_REASON_FOR_EXCLUSION>
<P>A randomised trial comparing the efficacy of tinidazole and metronidazole in 20 patients with amoebic liver abscess. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Khokhani-1978">
<CHAR_REASON_FOR_EXCLUSION>
<P>A randomised trial of 20 patients with amoebic liver abscess comparing tinidazole and metronidazole. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lasserre-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>A randomised double blind trial evaluating the efficacy of single-day treatment with either ornidazole or tinidazole in 72 patients with amoebic liver abscess. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-15 21:12:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mogollon-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-15 21:12:34 +0100" MODIFIED_BY="[Empty name]">
<P>Prospective, non-randomised study, in 170 patients, with a high proportion of puncture procedure (n=131). No outcomes were compared.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Morales-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>A randomised, double blind comparison of intravenous metronidazole and intramuscular emetine in acute amoebic liver abscess. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-15 21:16:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-N_x0027_Gbesso-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-15 21:16:22 +0100" MODIFIED_BY="[Empty name]">
<P>Non-randomised study, assessing medical treatment, ultrasound-guided puncture and surgical puncture. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Powell-1965">
<CHAR_REASON_FOR_EXCLUSION>
<P>A clinical trial evaluating dehydroemetine in the treatment of amoebic liver abscess. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Powell-1967">
<CHAR_REASON_FOR_EXCLUSION>
<P>A randomised trial comparing dehydroemetine and emetine hydrochloride in identical dosage in amoebic liver abscess. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Powell-1974">
<CHAR_REASON_FOR_EXCLUSION>
<P>A clinical trial of benzoyl metronidazole suspension in the treatment of amoebic dysentery and amoebic liver abscess. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rajak-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>A randomised trial including 50 patients with mixed amoebic and pyogenic liver abscesses who received either percutaneous needle aspiration or catheter drainage. No comparison was made to medical treatment alone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-21 03:32:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ramani-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-21 03:32:49 +0100" MODIFIED_BY="[Empty name]">
<P>Prospective non-randomised study, in 200 patients with ultrasound and serologic diagnosis of liver abscess. The 6-months response was not different among groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-10 11:03:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ruas-1973">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-10 11:03:14 +0100" MODIFIED_BY="[Empty name]">
<P>A comparative study of the effects of a novel anti-amoebic drug (RO 7-020) <I>versus</I> metronidazole in amoebic liver abscess. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-16 19:59:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Satpathy-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-16 19:59:04 +0100" MODIFIED_BY="[Empty name]">
<P>A randomised trial comparing intravenous metronidazole and intramuscular dehydroemetine in amoebic liver abscess.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-10 11:03:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Simjee-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-10 11:03:17 +0100" MODIFIED_BY="[Empty name]">
<P>A randomised trial of metronidazole <I>versus</I> tinidazole in 48 patients with amoebic liver abscess. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Singh-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>A randomised trial including 50 patients with drug resistant amoebic liver abscess who received a repeat trial of conservative therapy, needle aspirations, percutaneous catheter drainage, and open surgical drainage.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-14 11:57:59 +0100" MODIFIED_BY="dimitrinka nikolova" STUDY_ID="STD-Soh-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-14 11:57:59 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>A randomised trial comparing ornidazole verus tinidazole in patients with amoebic liver abscess. No comparison was made with percutaneous needle aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-14 11:58:03 +0100" MODIFIED_BY="dimitrinka nikolova" STUDY_ID="STD-Yu-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-14 11:58:03 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>A randomised trial comparing continuous catheter drainage and intermittent needle aspiration in 64 patients with pyogenic liver abscesses.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-10 11:03:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zafar-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-10 11:03:20 +0100" MODIFIED_BY="[Empty name]">
<P>This study is non-randomised. Forty-six patients with amoebic liver abscess received needle aspiration with antiamebic drug treatment <I>versus</I> drug treatment alone, based on size of the abscess.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-11-09 19:48:11 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2008-11-09 16:38:39 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-14 13:53:38 +0100" MODIFIED_BY="dimitrinka nikolova" RESULT="UNKNOWN" STUDY_ID="STD-Arredondo-1993">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-16 20:15:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Blessman-2003">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-16 20:32:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sharma-1989">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-16 20:34:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tandon-1997">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-16 20:40:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Van-Allan-1992">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-16 20:42:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Widjaya-1991">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-16 20:17:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-la-Rey-Nel-1989">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2008-11-09 16:38:39 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-16 19:58:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Arredondo-1993">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-13 08:02:59 +0100" MODIFIED_BY="Kate Whitfield" RESULT="UNKNOWN" STUDY_ID="STD-Blessman-2003">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-16 20:33:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sharma-1989">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-13 08:04:56 +0100" MODIFIED_BY="Kate Whitfield" RESULT="UNKNOWN" STUDY_ID="STD-Tandon-1997">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2000-01-01 05:45:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-Allan-1992">
<DESCRIPTION>
<P>Using a sealed-envelope procedure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-16 20:42:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Widjaya-1991">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-13 08:03:25 +0100" MODIFIED_BY="Kate Whitfield" RESULT="UNKNOWN" STUDY_ID="STD-de-la-Rey-Nel-1989">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2008-11-09 16:38:39 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-04-14 13:53:41 +0100" MODIFIED_BY="dimitrinka nikolova" RESULT="UNKNOWN" STUDY_ID="STD-Arredondo-1993">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-04-16 20:15:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Blessman-2003">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-04-16 20:32:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sharma-1989">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-06-13 08:04:54 +0100" MODIFIED_BY="Kate Whitfield" RESULT="NO" STUDY_ID="STD-Tandon-1997">
<DESCRIPTION>
<P>Patient and provider not blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2000-01-01 05:45:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Van-Allan-1992">
<DESCRIPTION>
<P>From randomisation status could not be obscured from the medical staff.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-04-16 20:42:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Widjaya-1991">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-04-16 20:17:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-la-Rey-Nel-1989">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2008-11-09 19:48:11 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Follow-up?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-14 13:53:51 +0100" MODIFIED_BY="dimitrinka nikolova" RESULT="UNKNOWN" STUDY_ID="STD-Arredondo-1993">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-11-09 19:23:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Blessman-2003">
<DESCRIPTION>
<P>28 days after discharge, all patients were re-examined at the end of the follow-up period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-11-09 19:30:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sharma-1989">
<DESCRIPTION>
<P>12 months, all patients were re-examined at the end of the follow-up period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-16 20:34:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tandon-1997">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-11-09 19:43:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Van-Allan-1992">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-11-09 19:48:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Widjaya-1991">
<DESCRIPTION>
<P>56 days, until resolution of abscesses, all patients were re-examined at the end of the follow-up period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-11-09 19:29:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-la-Rey-Nel-1989">
<DESCRIPTION>
<P>Monthly until complete resolution of the cavity, all patients were re-examined at the end of the follow-up period.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2008-04-13 16:29:30 +0100" MODIFIED_BY="[Empty name]"/>
<ADDITIONAL_TABLES MODIFIED="2008-04-10 10:46:51 +0100" MODIFIED_BY="dimitrinka nikolova"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-11-10 19:46:20 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2008-11-10 19:46:20 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Needle aspiration and metronidazole versus metronidazole alone</NAME>
<DICH_OUTCOME CHI2="0.22154482256471597" CI_END="1.6133547665081585" CI_START="0.22420934720260557" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6014392895421834" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.20772987649978694" LOG_CI_START="-0.6493462857914764" LOG_EFFECT_SIZE="-0.2208082046458447" METHOD="MH" MODIFIED="2008-11-10 19:46:20 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6378653712889825" P_Q="0.0" P_Z="0.31254822507975966" Q="0.0" RANDOM="NO" SCALE="347.26" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="37" TOTAL_2="41" WEIGHT="100.00000000000001" Z="1.0098895468982456">
<NAME>Proportion of patients remaining febrile</NAME>
<GROUP_LABEL_1>Aspiration + Metronidazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Metronidazole</GROUP_LABEL_2>
<GRAPH_LABEL_1>Worst Metronidazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Worst Aspiration + Metronidazole</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.4306686378614173" CI_START="0.044827122998956886" EFFECT_SIZE="0.39215686274509803" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.535378772355789" LOG_CI_START="-1.3484591332236995" LOG_EFFECT_SIZE="-0.4065401804339552" MODIFIED="2008-08-15 19:15:56 +0100" MODIFIED_BY="[Empty name]" ORDER="5" O_E="0.0" SE="1.1065757108854182" STUDY_ID="STD-Sharma-1989" TOTAL_1="17" TOTAL_2="20" VAR="1.2245098039215685" WEIGHT="32.016536518144235">
<FOOTNOTE>Fever on 10th day</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="2.1178406337671647" CI_START="0.23136773947357858" EFFECT_SIZE="0.7" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.32589327660265943" LOG_CI_START="-0.6356971965741458" LOG_EFFECT_SIZE="-0.1549019599857432" MODIFIED="2008-08-15 19:22:38 +0100" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.5648430038936652" STUDY_ID="STD-Van-Allan-1992" TOTAL_1="20" TOTAL_2="21" VAR="0.319047619047619" WEIGHT="67.98346348185578">
<FOOTNOTE>For at least 48 hrs.</FOOTNOTE>
</DICH_DATA>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="13.691043443117806" CI_END="2.428293278132115" CI_START="-3.0482487203089854" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.30997772108843524" ESTIMABLE="YES" I2="92.69595481049562" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2008-11-10 19:30:59 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="2.1548199824672487E-4" P_Q="1.0" P_Z="0.8244136686044284" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="3.6336814285714274" TOTALS="YES" TOTAL_1="35" TOTAL_2="35" UNITS="" WEIGHT="99.99999999999999" Z="0.22187181966871541">
<NAME>Days to resolution of fever</NAME>
<GROUP_LABEL_1>Aspiration + Metronidazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Metronidazole</GROUP_LABEL_2>
<GRAPH_LABEL_1>Better Aspiration + Metronidazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Better Metronidazole</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.361887258099173" CI_START="-3.2381127419008267" EFFECT_SIZE="-1.7999999999999998" ESTIMABLE="YES" MEAN_1="3.8" MEAN_2="5.6" MODIFIED="2008-04-16 22:11:19 +0100" MODIFIED_BY="[Empty name]" ORDER="7" SD_1="1.7" SD_2="2.2" SE="0.7337444734926134" STUDY_ID="STD-Tandon-1997" TOTAL_1="15" TOTAL_2="14" WEIGHT="46.784918610301254">
<FOOTNOTE>Units of effect measure in days.</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="1.3627585217029918" CI_START="0.6372414782970082" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="3.0" MODIFIED="2008-04-16 22:11:15 +0100" MODIFIED_BY="[Empty name]" ORDER="8" SD_1="0.74" SD_2="0.38" SE="0.18508427938696057" STUDY_ID="STD-Van-Allan-1992" TOTAL_1="20" TOTAL_2="21" WEIGHT="53.21508138969873">
<FOOTNOTE>Units of effect measure in days.</FOOTNOTE>
</CONT_DATA>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="4.501786766224357" CI_END="1.2642976346213641" CI_START="0.34680746243613236" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6621690527554424" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="17" I2="55.573195625225104" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.1018493254158996" LOG_CI_START="-0.45991156615555745" LOG_EFFECT_SIZE="-0.1790311203698289" METHOD="MH" MODIFIED="2008-11-10 19:31:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.1053052262893015" P_Q="0.0" P_Z="0.21156761900322152" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="57" TOTAL_2="60" WEIGHT="100.0" Z="1.249266559140974">
<NAME>Proportion of patients without resolution of pain</NAME>
<GROUP_LABEL_1>Aspiration + Metronidazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Metronidazole</GROUP_LABEL_2>
<GRAPH_LABEL_1>Worst Metronidazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Worst Aspiration + Metronidazole</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.345417134286264" CI_START="0.01372026275969937" EFFECT_SIZE="0.31746031746031744" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8660164637035079" LOG_CI_START="-1.8626375712827092" LOG_EFFECT_SIZE="-0.49831055378960054" MODIFIED="2008-04-10 18:29:11 +0100" MODIFIED_BY="[Empty name]" ORDER="9" O_E="0.0" SE="1.602824887206216" STUDY_ID="STD-Blessman-2003" TOTAL_1="20" TOTAL_2="19" VAR="2.5690476190476192" WEIGHT="9.142969209648951"/>
<DICH_DATA CI_END="3.302650530857286" CI_START="0.5704178488232117" EFFECT_SIZE="1.3725490196078431" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.5188626213602369" LOG_CI_START="-0.24380689352759602" LOG_EFFECT_SIZE="0.13752786391632046" MODIFIED="2008-04-10 18:29:19 +0100" MODIFIED_BY="[Empty name]" ORDER="10" O_E="0.0" SE="0.44799584832009864" STUDY_ID="STD-Sharma-1989" TOTAL_1="17" TOTAL_2="20" VAR="0.20070028011204483" WEIGHT="32.806432633849774"/>
<DICH_DATA CI_END="0.980627388756434" CI_START="0.1011852219687954" EFFECT_SIZE="0.315" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="-0.008495981149320214" LOG_CI_START="-0.9948829112714788" LOG_EFFECT_SIZE="-0.5016894462103995" MODIFIED="2008-04-10 18:29:26 +0100" MODIFIED_BY="[Empty name]" ORDER="11" O_E="0.0" SE="0.5794085654478071" STUDY_ID="STD-Van-Allan-1992" TOTAL_1="20" TOTAL_2="21" VAR="0.33571428571428574" WEIGHT="58.05059815650127"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="8.862888997004674" CI_END="-0.41638093044008206" CI_START="-2.768142085432934" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.5922615079365081" ESTIMABLE="YES" I2="88.71699735449737" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2008-11-10 19:32:13 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0029102903088882304" P_Q="1.0" P_Z="0.007954620112669494" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.638762380952381" TOTALS="YES" TOTAL_1="35" TOTAL_2="35" UNITS="" WEIGHT="100.0" Z="2.653989928270993">
<NAME>Days to resolution of pain</NAME>
<GROUP_LABEL_1>Aspiration + Metronidazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Metronidazole</GROUP_LABEL_2>
<GRAPH_LABEL_1>Better Aspiration + Metronidazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Better Metronidazole</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.6103022074163134" CI_START="-2.789697792583687" EFFECT_SIZE="-2.2" ESTIMABLE="YES" MEAN_1="0.7" MEAN_2="2.9" MODIFIED="2008-04-16 22:11:06 +0100" MODIFIED_BY="[Empty name]" ORDER="12" SD_1="0.7" SD_2="0.9" SE="0.30087174929496047" STUDY_ID="STD-Tandon-1997" TOTAL_1="15" TOTAL_2="14" WEIGHT="49.355125661375666">
<FOOTNOTE>Units of effect measure in days.</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="-0.4742638970479033" CI_START="-1.5257361029520968" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="3.0" MODIFIED="2008-04-16 22:11:03 +0100" MODIFIED_BY="[Empty name]" ORDER="13" SD_1="0.26" SD_2="1.2" SE="0.268237634517285" STUDY_ID="STD-Van-Allan-1992" TOTAL_1="20" TOTAL_2="21" WEIGHT="50.64487433862434">
<FOOTNOTE>Units of effect measure in days.</FOOTNOTE>
</CONT_DATA>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.5840285340454042" CI_END="1.3166555251009595" CI_START="0.6175597876837954" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9017280668439043" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.11947216591364919" LOG_CI_START="-0.20932099077400804" LOG_EFFECT_SIZE="-0.04492441243017942" METHOD="MH" MODIFIED="2008-11-10 19:33:34 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.44473772143801826" P_Q="0.0" P_Z="0.5922374571385437" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="33" TOTAL_2="37" WEIGHT="100.0" Z="0.5355964903699018">
<NAME>Proportion of patients without resolution of abscess size</NAME>
<GROUP_LABEL_1>Aspiration + Metronidazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Metronidazole</GROUP_LABEL_2>
<GRAPH_LABEL_1>Worst Metronidazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Worst Aspiration + Metronidazole</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.825777152153634" CI_START="0.12245153903306177" EFFECT_SIZE="0.5882352941176471" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.45113790931505243" LOG_CI_START="-0.9120357520716001" LOG_EFFECT_SIZE="-0.2304489213782739" MODIFIED="2008-08-15 19:37:24 +0100" MODIFIED_BY="[Empty name]" ORDER="14" O_E="0.0" SE="0.8007349565169709" STUDY_ID="STD-Sharma-1989" TOTAL_1="17" TOTAL_2="20" VAR="0.6411764705882352" WEIGHT="21.306494492973794">
<FOOTNOTE>Including partial and complete resolution at one year</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="1.3617072627171434" CI_START="0.714833269225891" EFFECT_SIZE="0.9866071428571429" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.13408375379471954" LOG_CI_START="-0.1457952430928237" LOG_EFFECT_SIZE="-0.0058557446490520885" MODIFIED="2008-08-15 19:34:51 +0100" MODIFIED_BY="[Empty name]" ORDER="15" O_E="0.0" SE="0.1644023081951213" STUDY_ID="STD-Widjaya-1991" TOTAL_1="16" TOTAL_2="17" VAR="0.027028118939883647" WEIGHT="78.6935055070262">
<FOOTNOTE>At four weeks</FOOTNOTE>
</DICH_DATA>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2008-11-10 19:34:17 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="20" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Proportion of patients without resolution of abdominal tenderness</NAME>
<GROUP_LABEL_1>Aspiration + Metronidazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Metronidazole</GROUP_LABEL_2>
<GRAPH_LABEL_1>Worst Aspiration + Metronidazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Worst Metronidazole</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.560449970126594" CI_START="0.18885185888216133" EFFECT_SIZE="0.5428571428571428" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.19324984922932026" LOG_CI_START="-0.7238787360242137" LOG_EFFECT_SIZE="-0.2653144433974467" MODIFIED="2008-04-10 18:43:33 +0100" MODIFIED_BY="[Empty name]" ORDER="16" O_E="0.0" SE="0.5387258708376408" STUDY_ID="STD-Blessman-2003" TOTAL_1="20" TOTAL_2="19" VAR="0.29022556390977444" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="2.6859705999911196" CI_END="-0.5390642432634827" CI_START="-2.856709566260327" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.697886904761905" ESTIMABLE="YES" I2="62.769510582010604" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2008-11-10 19:34:48 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.1012355879916641" P_Q="1.0" P_Z="0.004082634934423556" Q="0.0" RANDOM="YES" SCALE="14.73" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.45194047619047656" TOTALS="YES" TOTAL_1="39" TOTAL_2="42" UNITS="" WEIGHT="100.0" Z="2.871705303771412">
<NAME>Days to resolution of abdominal tenderness</NAME>
<GROUP_LABEL_1>Aspiration + Metronidazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Metronidazole</GROUP_LABEL_2>
<GRAPH_LABEL_1>Better Aspiration + Metronidazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Better Metronidazole</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.1750691763605285" CI_START="-3.624930823639472" EFFECT_SIZE="-2.4000000000000004" ESTIMABLE="YES" MEAN_1="4.5" MEAN_2="6.9" MODIFIED="2008-04-16 22:09:58 +0100" MODIFIED_BY="[Empty name]" ORDER="17" SD_1="2.2" SD_2="2.3" SE="0.6249761900226585" STUDY_ID="STD-de-la-Rey-Nel-1989" TOTAL_1="24" TOTAL_2="28" WEIGHT="41.4905753968254">
<FOOTNOTE>Units of effect measure in days.</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="-0.4523211105586502" CI_START="-1.9476788894413497" EFFECT_SIZE="-1.2" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="2.9" MODIFIED="2008-04-16 22:10:05 +0100" MODIFIED_BY="[Empty name]" ORDER="18" SD_1="0.8" SD_2="1.2" SE="0.38147583085145714" STUDY_ID="STD-Tandon-1997" TOTAL_1="15" TOTAL_2="14" WEIGHT="58.5094246031746">
<FOOTNOTE>Units of effect measure in days.</FOOTNOTE>
</CONT_DATA>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="11.320972318341259" CI_END="-0.5663562314992757" CI_START="-2.045212075993817" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.3057841537465462" ESTIMABLE="YES" I2="82.33367290581769" I2_Q="0.0" ID="CMP-001.08" MODIFIED="2008-11-10 19:35:13 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0034808327165861686" P_Q="1.0" P_Z="5.378217922289109E-4" Q="0.0" RANDOM="NO" SCALE="26.58" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="46" TOTAL_2="46" UNITS="" WEIGHT="100.0" Z="3.4611756412283508">
<NAME>Duration of hospitalisation</NAME>
<GROUP_LABEL_1>Aspiration + Metronidazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Metronidazole</GROUP_LABEL_2>
<GRAPH_LABEL_1>Better Aspiration + Metronidazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Better Metronidazole</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.1014984625614201" CI_START="-5.298501537438581" EFFECT_SIZE="-3.2" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="7.2" MODIFIED="2008-04-16 22:10:35 +0100" MODIFIED_BY="[Empty name]" ORDER="19" SD_1="0.6" SD_2="3.5" SE="1.070683723778239" STUDY_ID="STD-Arredondo-1993" TOTAL_1="11" TOTAL_2="11" WEIGHT="12.41575429074413">
<FOOTNOTE>Units of effect measure in days.</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="-0.7160998056992065" CI_START="-2.4839001943007943" EFFECT_SIZE="-1.6000000000000005" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="7.4" MODIFIED="2008-04-16 22:10:30 +0100" MODIFIED_BY="[Empty name]" ORDER="20" SD_1="0.8" SD_2="1.5" SE="0.4509777737105814" STUDY_ID="STD-Tandon-1997" TOTAL_1="15" TOTAL_2="14" WEIGHT="69.98182017692159">
<FOOTNOTE>Units of effect measure in days.</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="2.9624207140285366" CI_START="-0.5624207140285364" EFFECT_SIZE="1.2000000000000002" ESTIMABLE="YES" MEAN_1="6.2" MEAN_2="5.0" MODIFIED="2008-04-16 22:10:41 +0100" MODIFIED_BY="[Empty name]" ORDER="21" SD_1="3.46" SD_2="2.1" SE="0.8992107650601165" STUDY_ID="STD-Van-Allan-1992" TOTAL_1="20" TOTAL_2="21" WEIGHT="17.602425532334287">
<FOOTNOTE>Units of effect measure in days.</FOOTNOTE>
</CONT_DATA>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.511595414392863" CI_END="1.185941732663199" CI_START="0.24735236079036413" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.5416137805983681" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="23" I2="81.85643312300061" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.07406335192497138" LOG_CI_START="-0.6066839402691337" LOG_EFFECT_SIZE="-0.26631029417208113" METHOD="MH" MODIFIED="2008-11-10 19:36:08 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.018890905298781235" P_Q="0.0" P_Z="0.12515589005000236" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="52" TOTAL_2="58" WEIGHT="100.0" Z="1.533487070090959">
<NAME>Proportion of non-responders</NAME>
<GROUP_LABEL_1>Aspiration + Metronidazole</GROUP_LABEL_1>
<GROUP_LABEL_2>Metronidazole</GROUP_LABEL_2>
<GRAPH_LABEL_1>Better Aspiration + Metronidazole</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Better Metronidazole</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.5617372604981394" CI_START="0.0014422085162422858" EFFECT_SIZE="0.028462998102466792" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.2504667680554238" LOG_CI_START="-2.8409719442583072" LOG_EFFECT_SIZE="-1.5457193561568654" MODIFIED="2008-04-10 18:56:31 +0100" MODIFIED_BY="[Empty name]" ORDER="24" O_E="0.0" SE="1.5216755637090058" STUDY_ID="STD-Arredondo-1993" TOTAL_1="15" TOTAL_2="15" VAR="2.3154965211891207" WEIGHT="47.77878513145966"/>
<DICH_DATA CI_END="2.540549263282457" CI_START="0.4024112792410283" EFFECT_SIZE="1.011111111111111" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.4049276206453695" LOG_CI_START="-0.3953298548818321" LOG_EFFECT_SIZE="0.004798882881768708" MODIFIED="2008-04-10 18:56:48 +0100" MODIFIED_BY="[Empty name]" ORDER="25" O_E="0.0" SE="0.4700752024630697" STUDY_ID="STD-de-la-Rey-Nel-1989" TOTAL_1="37" TOTAL_2="43" VAR="0.22097069597069596" WEIGHT="52.22121486854034"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAeAAAAC1CAMAAACwPtxXAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAPkAAAGeCAIAAADZqzCRAAAQTElEQVR42u3dvY7kRBvF8ZZICCaY
YK+Aa5gIjQgQGffEhBusxIZzF4hLQCyEy0ZESMAOYifYYICMj5VfL/MK9U77o2xX2VXl31EHs73d
z3hc/358qmyfPhyI9qOGqHZhnbBOhHUirBNhnQjrRFgnwjoR1omwXshIGAusVz8MnT8T1mtm/b9R
wT3W62edsF7/SNgPWCfCOhHWCx4Pt9Fg3QyVsI51wjrWCev5m3VDg3UirBNhvUQbY4dgfS9zU0OD
dawT1rFOWOfX7Vv7lLBOhHVK4dSdN8U6EdZr7O7DzxDWqxgGHgbru+3rhHUirFdnZuwTrNfsYYR+
YX1frMMd61gnrNeFu3HBOhHWa2nqhHWsE9ZrGgzr61gnwjoR1ou1Mew71ncxN3UuCetYJ6xjnbBe
qF83LlgnwjoR1sv1MFGGhiPCer5z00Q1dz7QWN8R683RZfE7HHSs74t1fd3uyNSsR/Trdi/WCetU
tTvi1ykXGxMLR0mRWM+6+0a/HsYQY30vrBPWd8Q6D4P1TP163HExxFjf3RED63YE1rFO2xmYFJc6
8utYz7EBW43B+o6chvAMrGN9vo3Z7YcH61lb9lgexlkqrO/uiIF1rGMd61S1O8I6EdaJsE5xnUZ0
S+28KdZ3MYM0xFjHOtYJ61indfx69HHh17G+ryOGPmJHYB3rtB2U0T2MfYv1fLtvxLkpv471XbBO
WM91PHwTBtYpinvhYYiwTtu1YfsE67uYm/oUYR3rMyvLEcD6vlhv3G9KuZn16Nc5Yh3rOzpouLea
COu0hY1pXCCA9Z3YjOiu2qcI67tg3dwU61jHOm3t1xN9NxjWse5ThHUirFPq1mtosL67qWr0ajwM
VYu7O1mxjnWsUx5+PV1xHoYI60RYp3QeJqLlsJqJ9XwnoymuEdBK7IjsQI/LqCHGOtaxTnlY9qQz
AawTYZ0I6xTdbDSJv8sX65TF3HSF73zk1wnrWCesY52KcNX8OtYJ60RYp3Usu/tNsW5uWv/cNOGM
BWdYz3A/NCnSW3FWN+tNUeswDzYv1olkrOd47N6zq073h2Odcv/MY50I60RYpyLpjDSfxvpOucl/
0KOvk2I9UyKbEjIzkn5ssF456H0/ZMj6ChcdxP0VWMd6nJrRD0fRU9CwvhfWo/v14rDBes0rD+ts
LdaJ8joWYT1HD5PCJ5R+D565ac09LOLQJE2KXC1AT1+vua+XcsQYmF5jnSpxR32Vo1kO1wjsx8xk
7tfTsZ5q34Isq+6bLS7hnyKs0wTWG98RkGIabYfWyvp/h4hyv2sA6/XjXqiHSXHvHNZp6QwyHxD7
0OTXaX7TTX2WKtH2Y71+LvPvvmvuHKxbf6jw86mvwz3TGSS/TrksQRz/UN5F5/p69X49+mem3JV7
fp02Y11fpwJwL2jWy6/vxcPkPI8sa2uxnvVktCCbkWibXb++C9Cjo5PuyyoSbbPcL6yrjPUaLXsp
R4withnrPkV72Was084+7XZEbp2sKfZ+U2uONMGhFvSdj4lyYFKs3GN9F6yXeF+Svo51rGO9Lr9e
yppjomR3Hoay+xSVtwegQFinDZpuEQ14hXs1nEvaxfQ0lqUu8VOUaI6B9ZpH197AOtYL8F1Y35dx
37OH4deJsF7p2ORc+cGVavkvHGE90wN35pX7loyy/UZsrOeIeLpIxBVuYI3LevzVeqhtDnqixrZO
ZayTvo51qsKvJ1rNdJ3jTqEvq3IBTQRYhHUirBNhnQjrRFjfyY6m9ML69qyrvG1lrGMd64QbrBNu
sE6IxDrWEYl1rN/rzZu73357fHt7eXNz/vPPh5cvz169uri7u3rz5rXKUSpjPQvW//jj+ubmUTuo
p492sH///anKyytjfXvW23bVOa7Hj/Y1Ki+sjPWNWW972OjQ3j/6+pnK27OeSZr9pLd3Zk2d7qLw
J4c3o3Wlxwfrr78+fPTR4f333z4+/fTw3XcPD9///HOr8ozKaVmPeHfjaqx34nv6c/iTo5vRTr+O
x++DD95uwJdfHr744u0PH34YdOxWOTvWj5958L8DbfK0yINXHgfxzHj78IczItadT97eXnYeoH/4
4e1Gtv3swfOvXl2oPKPyBqw/gDuEp5BXDnzN0Ojbh/dUatbvF9QePL7//vDxx4f33jt8/vnD/3r5
8kzlGZUTsj4JkYU+IaLNGGC97xPVdzAJHIPONvbJJ2+LfPZZ95xM5RmV07J+ej3xAN+BL16f9WEv
lKivtz2s1Y8/dgztwh6528o59vX1m/2kPRX9yT6H2vdY7n33WTkV630R8fM8zMJmv5pfj7IOc/+4
V/g5FJWLYT3KOkyfNQpfh8lhfX14dJesVe+8svOmzps6b0orst64amWtyljfnvXm/1f2nfdf2fdE
5eWVsZ4F603/FdudrlRlrBfMusqpK2Md61gn3GCdcIN1QiTWsY5IrO+HdZLTq6+rrK9jXWWsY11l
rGNdZaxjHetYxzrWab3RlaZ7rLu/7x6/fHz54vL8m/PDV4ezZ2cXzy+ufrp6/Zec3sJZl6Z7rOtf
rx99+6hF/PTRov/0Fzm9xbLu7qFjtc27k/LjR/sarJfHurtCH3T0UdDvH33dPYsspKQzkribHfHJ
4b9dmu4Dj95nXTrNzO2ft1mw3vnPnFlPHbQkTXe0cjsZDQR9wMnkyPqSfnmazTvvXaPbL6d3zcqX
Ly47mL5XF+sXzy8KYH15Ew3M6W0CMsA2ZF2a7rHulxfDWT97lkee47BfH30ynJtw8gJnDvMyhPsO
L8O/UZruO092Un6sE9zL6Ot9H4ZwNzL6c2BQcETWo/T13abpltrXwz1MeBcMj/yNnr++sl/fZ5ou
v35Ywvqkvt6XurraOszO03RLXYcZXV9fvg4T4mHCcVxoqxo5vYsrF7m+TnWf3XTelOaw3rge5l25
HqZm1htpuifdvXtN5l/r8uRGTm/JrDfSdE+8e+f1650eHeuFsa5y6spYxzrWCTdYJ9xgnRCJdawj
Euv7YZ3k9OrrKuvrWFcZ61hXGetYVxnrWMc61rGOdVpvdOX0HktOb7Wsy+k9lpzeall3X9Kx3JdU
LevuN33Q0TO63zTwxeEvCzzBO/XXBabYhdSR07tO5exyBKKzHmWG3kne1M0bLiKnN3XlXPJhTuNW
hjvZjJeNvnE4SLEJyLsb/b0rsy6n91hZ5H7NiNGa+rKQN85jPTwndX3W5fQeK4s8xxmjG97FA0PC
BrpvMxijF4X10TCwgST4gd8op/edJ3PI6R0Y1D5/MhyZO1x5oP4o66evGagT/mlswtIk+zavkdNb
TV8ftj3h7T/QCUxlfck6TCy7Iqd3R359tK83waGkId6jCL8up7fOdZipc9OBZeyF6znZrq/L6ZXT
G2EB3nlT500LY73cyxlcDxNY2fUwxUtOb3hlOb01s97I6T3x7nJ6q2Vd5dSVsY51rBNusE64wToh
EutYRyTW98M6yenV11XW17GuMtaxrjLWsa4y1rGOdaxjHeu03ujK6T2WnN5qWZfTeyw5vdWy7r6k
Y7kvqVrW3W/6oKNXe7/paOLX5kTK6V2tcs05AgOBcht+8Pq2UE5v6sq55MOsz3pI4zyOnTl916TW
K6d388pZ5H6tbGE7U7tGg0IHfg7EsZHTu2nlLPIcN/Trw9zEysQLOdTI6U1dOYuc3pXb/OhXBsxm
ffQqZzm9G1auua+HzE3nOYd5NqOR07tp5R359UCsZ/f1UZvRyOndtHLN6zBT/fokOzHDZjRyejet
LKe3EjlvGlJZTm/NrDeuh3lXroepmfVGTu9Jd5fTWy3rjZzeE+8up7da1lVOXRnrWMc64QbrhBus
EyKxjnVEYn0/rJOcXn1dZX0d6ypjHesqYx3rKmMd61jHOtaxTuuNbolpun/f3b18/PjF5eU35+df
HQ7Pzs6eX1z8dHX11+sctxnrWbBeYprur9fX3z561Hk3RYv+L0+z22asb896iXcPtc179Ea59jVZ
bTPWN2a9xLtC244eeLN/X3dff5ubrHIERs/xrjDjmZ0jMPonVJOm23r0PuvSaWb+vN1+m/Pq61G2
YWGRJTm9o5tRTZpuOxmdEuLS7WRW3ubcWR9I5e3ssk1PnN3o2x/870LWJ+XDlJim++LychLrzy+2
3+asWQ9J5Q3535AXzNiMkNeHjEGJabr3y4vhj2dn229zMR4mVs7jkkzqvo/ZQtZLTNPtS1zsD9Pd
fpuL8TAbsj5skBL19czTdFfu61G2uUgPsz7r4TPO4d1YTZru+n59+TaXwXp4X593BIjo12ewXmKa
7mrrMBG3uQwP08wN+Z/xdR3N4pzeqayXmKa72vp6xG3Oi/Xq5bzpttuM9SwWmlwPs842Y3171psy
03Tb7t63JtM+f/Mku23GehasN2Wm6fZdv97p0TffZqznwrrKqStjHetYJ9xgnXCDdUIk1rGOSKzv
h3WS06uvq6yvY11lrGNdZaxjXWWsYx3rWMc61mm90U2Xpnv3993jl48vX1yef3N++Opw9uzs4vnF
1U9Xr/+S00urs54uTff61+tH3z7qvJmiRf/pL3J6aUXW092J0zbv0fvk2tfMqOy+JJrMero7LNuO
Hnivf193d79phGFeHjLa+c8Nc3r7nhz+k9Ml07Yevc+6dJqZ2z/l9ObHemc8RqyPUNxIptE/OV0y
bTsZPUyJcel0MnJ6l+K+JE03nPWtcnonPZkumfbyxeWhL3mxC8mL53J6U7I+L003hPWtcnqnPpku
mfZ+eTGc9bNncnoT9/WpJIUjPoPRZnFObzMxKTJdMu1Ilm4X8YGV5fTO8dlNcBhv5+tH2/mkysO/
sQnL6Z3Kerpk2mr6epE5vQPeI3pf3ySnd8bb0yXT1uTXi8zpnR3GO4z+ki/biOjXs8rprWAdpuyc
3iVhvJNYn1p5+fp6lO/Bi5hMW8H6upzeUuW86bZ7A+vbs964HmatvYH17VlvUqbptt29e03mX+vy
5EZOL63LepMyTbfv+vVOjz6pspxemjO6KqeujHWsY51wg3XCDdYJkVjHOiKxvh/WSU6vvq6yvo51
lbGOdZWxjnWVsY51rGMd61in9UY3XU5viZVTZAtjPQvW0+X0llg5UbYw1rdnPd2dOCVWTncvFdY3
Zj3dHZYlVk53j+zGrA/HBPSFDTVRg3lH99SkSN6p+TDpkmlLrJwu+yAv1oeTktaZxS/J6W0G81ab
1ZNpS6ycLtMma9bnRb6MJh+N5rcszKSOlfu1PJm2xMrpssqy8Ot9rEyN8go5RKTO/ZrBerpk2hIr
p8ugzIj1GQ1+4A8L6bWJcnqnsp4umbbEyumyhWtjvS+Yd/g1gXPTJiynN0pfj5JMW2JlfT2I9RAP
vauc3hIrV+7Xm1nB04Fuvgn4go1t/Xq6ZNoSK9e8DjOJ9cB1mFEWhxdMtl1fj5hMW2LlmtfX052M
TL0SH3FTnTc9VrXnTfcDeuN6mODKrocpXlvl9JZYOVG2MNZzOQqly+ktsXKKbGGs58K6yqkrYx3r
WCfcYJ1wg3VCJNaxjkis74d1ktNLtGK7sSMI60RYJ8I6EdaJsE6EdaKYrBPtQf8DiMtSDgaoTqMA
AAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NO="3" REF_ID="CMP-001.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Needle aspiration and metronidazole versus metronidazole alone, outcome: 1.1 Proportion of patients remaining febrile.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA3YAAADQCAMAAAB83gPRAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NO="4" REF_ID="CMP-001.02" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Needle aspiration and metronidazole versus metronidazole alone, outcome: 1.2 Days to resolution of fever.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA5UAAADACAMAAACj3bc4AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NO="5" REF_ID="CMP-001.03" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Needle aspiration and metronidazole versus metronidazole alone, outcome: 1.3 Proportion of patients without resolution of pain.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA3YAAACwCAMAAAB0KgyLAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NO="6" REF_ID="CMP-001.04" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Needle aspiration and metronidazole versus metronidazole alone, outcome: 1.4 Days to resolution of pain.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA5UAAADACAMAAACj3bc4AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NO="7" REF_ID="CMP-001.05" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Needle aspiration and metronidazole versus metronidazole alone, outcome: 1.5 Proportion of patients without resolution of abscess size.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA3YAAADQCAMAAAB83gPRAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NO="8" REF_ID="CMP-001.06" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Needle aspiration and metronidazole versus metronidazole alone, outcome: 1.6 Proportion of patients without resolution of abdominal tenderness.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA3YAAABgCAMAAABmFBCkAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-09" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NO="9" REF_ID="CMP-001.07" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Needle aspiration and metronidazole versus metronidazole alone, outcome: 1.7 Days to resolution of abdominal tenderness.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA6YAAADACAMAAAAgGY4DAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-10" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NO="10" REF_ID="CMP-001.08" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Needle aspiration and metronidazole versus metronidazole alone, outcome: 1.8 Duration of hospitalisation.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA5AAAADgCAMAAABCWHlKAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-11" MODIFIED="2008-11-18 11:40:13 +0100" MODIFIED_BY="dimitrinka nikolova" NO="11" REF_ID="CMP-001.09" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Needle aspiration and metronidazole versus metronidazole alone, outcome: 1.9 Proportion of non-responders.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA3YAAACgCAMAAAB3/A4QAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-10-27 11:45:49 +0100" MODIFIED_BY="dimitrinka nikolova">
<APPENDIX ID="APP-01" MODIFIED="2008-10-27 11:45:49 +0100" MODIFIED_BY="dimitrinka nikolova" NO="1">
<TITLE MODIFIED="2008-04-10 10:46:30 +0100" MODIFIED_BY="dimitrinka nikolova">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2008-10-27 11:45:49 +0100" MODIFIED_BY="dimitrinka nikolova">
<TABLE COLS="3" ROWS="6">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Database</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Time of search</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Searched Items</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The Cochrane Hepato-Biliary Group Controlled Trials Register</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>September 2007.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(metronidazole OR 'image-guided percutaneous' OR (needle AND (aspiration OR biops*)) OR 'catheter-drain*') and (amoeb* OR ameb*AND (liver OR hepatic) AND abscess*)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cochrane Central Register of Controlled Trials (CENTRAL) in The<BR/>Cochrane Library</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Issue 2, 2007.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 MeSH descriptor Metronidazole explode all trees in MeSH products<BR/>#2 MeSH descriptor Biopsy, Needle explode all trees in MeSH products<BR/>#3 MeSH descriptor Drainage explode all trees in MeSH products<BR/>#4 metronidazole OR image-guided percutaneous OR needle aspiration OR catheter drain* in All Fields in all products<BR/>#5 (#1 OR #2 OR #3 OR #4)<BR/>#6 MeSH descriptor Liver Abscess, Amebic explode all trees in MeSH products<BR/>#7 am*eb* AND (liver OR hepatic) AND abscess* in All Fields in all products<BR/>#8 (#6 OR #7)<BR/>#9 (#5 AND #8)<BR/>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MEDLINE</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1950 to October 2007.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 explode "Metronidazole"/ all subheadings<BR/>#2 explode "Biopsy-Needle"/ all subheadings<BR/>#3 explode "Drainage"/ all subheadings<BR/>#4 metronidazole or image-guided percutaneous or needle aspiration or catheter drain*<BR/>#5 #1 or #2 or #3 or #4<BR/>#6 explode "Liver-Abscess-Amebic"/ all subheadings<BR/>#7 am*eb* and (liver or hepatic) and abscess*<BR/>#8 #6 or #7<BR/>#9 #5 and #8<BR/>#10 am*eb* AND (liver OR hepatic) AND abscess*<BR/>#11 #9 and #10<BR/>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EMBASE</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1980 to October 2007.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 explode "metronidazole"/ all subheadings<BR/>#2 explode "needle-biopsy"/ all subheadings<BR/>#3 explode "percutaneous-drainage"/ all subheadings<BR/>#4 metronidazole or image-guided percutaneous or needle aspiration or catheter drain*<BR/>#5 #1 or #2 or #3 or #4<BR/>#6 explode "liver-amebiasis"/ all subheadings<BR/>#7 am*eb* and (liver or hepatic) and abscess*<BR/>#8 #6 or #7<BR/>#9 #5 and #8<BR/>#10 random* or blind* or placebo* or meta-analysis<BR/>#11 #9 and #10<BR/>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Science Citation Index Expanded (http://portal.isiknowledge.com/portal.cgi?DestApp=WOS&amp;Func=Frame)<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1945 to October 2007.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 TS=(metronidazole OR image-guided percutaneous OR needle aspiration OR catheter drain*)<BR/>#2 TS=(am*eb* AND (liver OR hepatic) AND abscess*)<BR/>#3 #2 AND #1<BR/>#4 TS=(random* or blind* or placebo* or meta-analysis)<BR/>#5 5 #4 AND #3<BR/>
</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>